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SUMMARY
The work outlined in this thesis was conducted between October 
1986 and November 1989 and is primarily concerned with the chiral 
and stereoselective synthesis of substituted 1,2,3,4,5,6 -hexahydro-
2,6-methano-3-benzazocine derivatives.
(-)-(l/?,2S,4/?,6/?)-l,2,3,4,5,6-Hexahydro-8-methoxy-l,3,4,6-tetra- 
methyl-2,6-methano-3-benzazocine was synthesised in 8 6 % enantiomeric 
excess from the t r a ns-r\ 6 -chromium tricarbonyl complex of 
(+)-(2R ,1 ’S )-l-(l,2-dihydro-7-methoxy-l,4-dimethyl-l-naphthyl)-W - 
methyltrifluoroacetyl-2 -propylamine by treatment with ultrasound 
in a methanolic solution of potassium carbonate. Chirality was 
introduced into the synthetic route using an Enders’ type 
C-alkylation of the (S)-l-amino-2 -methoxymethylpyrrolidine hydrazone 
of 4-(3-methoxyphenyl)-4-methylcyclohexanone. A Beckmann 
rearrangement of the chiral cyclohexanone, followed by ring opening 
of the resulting caprolactam gave an aminooctanone derivative, which 
was converted to (+)-(2/?,l’S)-l-(l,2-dihydro-7-methoxy-l,4-dimethyl-
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1.1 B io log ica l a n d  P h arm aco log ica l B ack grou n d  to  th e  P r o je c t
The latex obtained by incision of the unripe seed capsule of the 
poppy, Papaver somniferum, and known as opium, is the source of 
several important alkaloids. The use of poppy juice to induce a sense 
of euphoria and sedation was first recorded by Theophrastus in the 
third century B.C.
In 1803 the German pharmacist, Seturner, isolated morphine (1) 
as one of the active ingredients of opium (which he named after 
Ovid’s god of dreams), but its structure was not elucidated until 120 






Morphine is of great clinical value, because of its ability to 
relieve severe pain without rendering the subject unconscious. 
However, in addition morphine also induces drowsiness; alters mood, 
often causing euphoria and physical dependence; reduces 
gut/intestinal tract motility; causes nausea and vomiting, and exerts a 
direct action on the respiratory centre by reducing its 
responsiveness to carbon dioxide tension. The latter effect can lead to 
respiratory collapse and death in the case of overdose. Regular use of 
morphine can lead to morphine tolerance in the subject, requiring
- 2 -
greater and greater doses to give the same effect.
A need to produce analgesic drugs which do not possess the 
adverse effects described above, has prompted much research in the 
field of opioid chemistry.
Morphine and related compounds act upon pain receptors in the 
central nervous system to produce an analgesic effect. However, the 
precise nature of these receptors is not known. In 1976 Martin et 
a I . 3 described three different syndromes, produced by the 
congeners of morphine in the non-dependent chronic spinal dog, that 
were attributed to three distinguishable receptors. (The existence of 
more than one receptor type had been predicted for some years 
before on the basis that certain hexahydro-2,6-methano-3-benzazocines 
have a different biological effect to that of morphine.)
Three receptors types were suggested: (morphine is the
typical agonist), k- (agonised by ketocyclazocine, 2 ) and o- (agonised 





isolation of the endorphins and enkephalins (analgesic peptides 
related to the body's natural pain killing compounds) that a fourth 
receptor site called the 8 -receptor (found to be plentiful in mouse 
vas deferens tissue) was proposed . 4
Of these receptors, the Ji-receptor site is linked with analgesia 
and the a-receptor site is linked with psychotomimetic effects,
- 3 -
whereas the effects of the k -  and 8 -receptor sites remains unclear. 
Most opioid drugs act at more than one receptor and to varying 
degrees. This complicates the interpretation of events further.
Hexahydro-2,6-methano-3-benzazocines are of interest, because 
most studies report both analgesic agonist and antagonist responses 
in a variety of tests, with "side effects" such as dependence and
respiratory depression being greatly reduced. These compounds are 
thought to differ from morphine in that they are agonists of the 
k- receptor. The topic of pain receptor sites is too large and complex 
to be fully discussed here, but various in depth discussions exist
elsewhere in the literature . 5
1.2 S y n t h e s e s  o f  S u b s t i tu te d  H exah ydro—2,6 -m eth a n o —3 -b e n z a z o c in e s
There are two principal approaches to substituted hexahydro-
2,6-methano-3-benzazocines. These are the tetralone route, originally 
performed by Barltrop6  and later adapted by May et al . , 7 and the 
Grewe cyclisation® of tetrahydropyridines. A short summary of the 
main variants of these two routes follows. Routes involving dihydro­
naphthalenes as the precursor to the target compounds, as well as 
existing chiral syntheses are also detailed below.
1.2 .1  T he T e tr a lo n e  R oute
The synthesis of 3,6-dimethyl-l,2,3,4,5,6-hexahydro-2,6-methano-
3-benzazocine by May e t  a I . 7 (see Scheme 1) involves initial
alkylation at C-l of a 1-alky 1-2-tetralone (4) with 2-chloro-
A/,W-dimethylethanamine, followed by bromination at C-3 and 
subsequent ring closure with aqueous ammonia. Heating leads to 
N - d e m e t h y la t io n  of the quaternary ammonium salt (7) to the tertiary  
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method, gives the required hexahydro-2,6-methano-3-benzazocine (10).
Low yields in the C-l alkylation of the 2-tetralone (4) and the 
W-demethylation of the quaternary salt (7) (see Scheme 1) led to the 
alternative strategies of Takeda and others9 and of May and 
Murphy1 0  shown in Scheme 2 and Scheme 3 respectively.
The route shown in Scheme 2 involves treating the alkylated 
2-tetralone (5) with ethyl chloroformate to give the ethyl carbamate
(1 1 ), which on hydrolysis of the carbamate group forms an enamine
(12). Bromination of the enamine (12), followed by hydrolysis and 
















The route of May and Murphy1 0  uses a 1-tetralone derivative 
(19) as an intermediate. This 1-tetralone (19) is synthesised from
2-phenylpropanonitrile (15), which is treated with base and then 
alkylated with 2-chloro-N ,A/-dimethylethanamine. Several steps then 
lead to the formation of the acid (18), which is converted to the 
1-tetralone (19) by a cyclodehydration reaction using polyphosphoric 
acid (PPA). From the 1-tetralone (19) onwards the route closely 
resembles the one of May e t a I .  7 shown in Scheme 1.
4-Phenyl-l-tetralone (24) has also been used as a starting 
material in the synthesis of 6-phenyl-l,2,3,4,5,6-hexahydro-2,6- 
methano-3-benzazocine. 1 1  (See Scheme 4.) 4-Phenyl-l-tetralone (24) is 
firs t brominated and then the bromide undergoes a nucleophilic 






























































protected amine (25). Hydrogenation over a catalyst of palladium on 
barium sulphate reduced the carbonyl and benzyl functionalities. 
Treatment with chloroacetyl chloride gave the chloroacetamide (27), 
which underwent ring closure in the presence of sodium hydride. 
Reduction with lithium aluminium hydride gave the required
3-methyl-6-phenyl-l,2,3,4,5,6-hexahydro-2,6~methano-3-benzazocine 
(29).
1.2 .2  T he G rew e C y c lisa tio n
In an analogous route to a synthesis of morphinans from
1,2,3,4,5,6,7,8-octahydroisoquinolines by Grewe, 8 May and Fry 1 2 
prepared substituted hexahydro-2,6-methano-3-benzazocines (see 










with either benzyl or p-methoxybenzyl magnesium chloride, in ether, 
readily gives dihydropyridines of the required structure (32). 
Dihydropyridines of this type rapidly decompose, presumably by an 
auto-oxidative mechanism, unless trapped as stable perchlorate 
salts . 1 3  Reduction of the dihydropyridine (32) to the tetrahydro- 
pyridine (33) is accomplished using sodium borohydride. Ring closure 
to give the hexahydro-2,6-methano-3-benzazocine (34) is brought 
about by treatment with poly phosphoric acid or hydrobromic acid.
In the case of 3,4-dialkyl and 3-alkyltetrahydropyridines the 
predominant product is the c is -  or a-compound (see Scheme 6 ). 
However, it is the trans- or 0-compound that is observed to be the 
greater analgesic in rodent studies.
For (36, R = Me, R’ = Me), only 1% of the trans- or P-isomer 
was isolated. In contrast 3-alky 1-4-phenyltetrahydropyridines (37) 
give mainly the trans- or P-isomer (see Scheme 7). Yokoyama et 
a I. 1 4  suggested that in this case the 4-phenyl group stabilizes the 




















intermediate is less sterically hindered than the c is-b en zy l 
intermediate.)
An alternative approach to the formation of the 2-benzyl- 
tetrahydropyridine (33) employs a phenyl lithium induced Stevens’ 
rearrangement introduced by Fry and May. 1 5  On adding phenyl 
lithium to the benzyl tetrahydropyridine salt (40) rearrangement 











1.2 .3  S y n th e s e s  U s in g  D ih y d ro n a p h th a len e  In ter m e d ia te s
Several syntheses of hexahydro-2,6-methano-3-benzazocines (41) 





intermediates in the formation of the fined ring.
May and Inoue1 6  first synthesised the 1,2-dihydronaphthalene 
(44), in four steps, from a 1-tetralone (43) intermediate. Treatment 
with mercuric acetate led to ring closure by means of attack of the 
mercury(II) -  double bond complex by the amino group. As can be 























stereo-con trol in the hydroxylation at C-l, but leads to some 
epimerization at C -ll.
In recent years other syntheses using dihydronaphthalenes 
have been developed. Kametani et a I,17 have designed a synthesis 
employing N-chlorosuccinimide (NCS) to form a A/-chloroamine. 
Decomposition of this W-chloroamine on silver oxide in the presence of 
methanol gives the l-m ethoxy-lf2,3t4,5,6-hexahydro-2t6-methano-3- 
benzazocine (52) in a stereoselective manner (see Scheme 10). In a 
related synthesis of a morphinan (53) Kametani et a I .  1 8  decomposed 
the A/-chloroamine on titanium(III) chloride in the presence of 
dichloromethane to give the chloro derivative instead of the methoxy 
compound.
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of aziridinium salt as an intermediate. This aziridinium salt (55) was 
formed by treating the 1,2-dihydronaphthalene (54) with bromine and 
then treating the dibromo compound formed with base. On heating the 
aziridinium salt (55) to 100° C, rearrangement took place to give the
-1 3 -




1) Br2 /CHC13  
i i )  DMF/NaHCO
(55)
(56)
The synthesis of Broka and Gerlits2 0  combines both the use of 
a A/-chloroamine derivative and an aziridinium intermediate. (See 
Scheme 12.) This time copper(I) and copper(II) are used to catalyse 
the addition of the A/-chloroamine to the double bond to give the 
pyrrolidines, (58) and (59). Only the pyrrolidine (58), where the 
chlorine atom is in a trans -configuration with respect to the nitrogen 










1.2.4 Chiral Syntheses of Hexahydro-2,6-methano-3-benzazocines
At the time of writing there are only three notable chiral 
syntheses of hexahydro-2,6-methano-3-benzazocines in the literature 
and two of these are based on the chiral synthesis of 
tetrahydropyridines from which the final product is obtained by 
means of a Grewe cyclisation (see Chapter 1.2.2).
Meyers et a I . 2 1  use a chiral formamadine auxiliary, which is 
attached to the nitrogen of the tetrahydropyridine (62), to perform a 
chiral alkylation using p-methoxybenzyl chloride as the alkylating 
agent. (See Scheme 13.) An enantiomeric excess of 98% was reported 
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because this synthesis relies on a Grewe cyclisation as its final step, 
the major product will always be the a-product, which, as stated 







Noyori et a I. 22 devised a similar type of chiral synthesis, this 
time relying on the chiral hydrogenation of the enamide (6 8 ) using a 
chiral ruthenium-binap catalyst. This route gave an enantiomeric 
excess of 97%. (See Scheme 14.) Again only the a-compound is
-1 6 -
















When R = Me, 
a-Metazocine (3)
Recently a chiral synthesis of a morphinan (75) was published 
by d ’Angelo et al,,23 which uses a chiral enamine (see Scheme 15) 
to induce asymmetry into the molecule. The final ring closure is 
performed using a route similar to those discussed in Chapter 1.2.3 
with a dihydronaphthalene intermediate. In this case the double bond 
is converted to an epoxide (74), which is attacked by the amino group 
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2.1 B a sis  o f  th e  P r o je c t
The structure-activity relationships of the different opioid 
receptors (see Chapter 1.1) are not fully understood, motivating 
further investigation of novel compounds to increase knowledge of the 
receptor sites. This has the ultimate goal of producing a 
non-addictive pain killing drug.
There are relatively few chiral syntheses of 1,2,3,4,5,6 - 
hexahydro-2,6-methano-3-benzazocines in the literature (see Chapter 
1.2.4), most relying on chiral resolution as a final step. It was our aim 
to construct a flexible route to these compounds, which is both 
stereo- and enantioselective.
A 1,3,4,6,8-substitution pattern was chosen for our target 
molecule, since this substitution pattern 2 4  has received little 
attention, and compounds substituted at C-42 5  are rare. The route 
selected (see Scheme 16) relies on the introduction of chirality via 
alkylation of a 4,4-disubstituted cyclohexanone (76). Enders* chiral 
hydrazone method2 6 was selected for this purpose. After separation 
of the resulting two diastereomers by column chromatography, the 
dimethylcyclohexanone (78) was converted into the oxime (102) and 
then subjected to a Beckmann rearrangement to give the caprolactam 
(109). A/-Methylation, followed by treatment with methyl lithium and 
trifluoroacetic anhydride quench afforded the ring opened trifluoro- 
acetamidoketone (81). Cyclodehydration yielded the dihydronaphthalene 
(1 2 0 ), which was treated with chromium hexacarbonyl to selectively 
give the chromium complex (82). Sonication of the chromium complex 
(82) with potassium carbonate in aqueous methanol led slowly to the
-1 9 -
Scheme 16
i) SAMP, 60°C 
i i )  KDA/Et20, 
-78°C _
i l i )  MeOTos, 
-110°C
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formation of a ring closed product, which was decomplexed to give 
the hexahydro-2,6-methano-3-benzazocine (83).
-2 0 -
2.2 Synthetic Work Towards the Production of Chiral 1,3,4,6,8-Penta- 
Substituted Hexahydro-2,6-Methano-3-Benzazocines
2.2.1 The Large Scale Synthesis of the Cyclohexanone (76)
The literature route to 4,4-disubstituted cyclohexanones2 7 (see 
Scheme 17) involves first the formation of the aldehyde (88) and then 
a Robinson annulation using methyl vinyl ketone (MVK) to give the 
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In our hands, synthesis of the aldehyde28 (88) was attempted 
by several other routes, however none of those tried gave a better
-2 1 -
yield on scaling up than the literature route. This employs a Darzen’s 
glycidic ester reaction, followed by ring opening of the epoxide, 
hydrolysis of the ester and subsequent decarboxylation of the 
corresponding acid (87). (These steps are shown in Scheme 17.)
Ring opening of the epoxide was carried out by stirring it in 
ether containing a few drops of concentrated sulphuric acid. This 








(85) ( 86 )
free acid using aqueous 2M sodium hydroxide solution.
Steam distillation of the product acid (87) in 3M sulphuric acid 
effected decarboxylation, yielding the required aldehyde (88). Since 
this compound is prone to side reactions steam distillation also has 
the advantage of removing it from the reaction mixture. The probable 









yield of 30% was obtained for the aldehyde (88) (on a one molar
-2 2 -
scale).
Another route tried involved the use of a Wittig reaction with 
the ylid (91), followed by demethylation by perchloric acid (see
Scheme 20). This gave the aldehyde (88) in a 27% yield when
performed on a small scale, but on scale up the by-product,
triphenylphosphine oxide, was difficult to remove and contaminated
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Rearrangement of the epoxide (92) with boron 
trifluoride-etherate was also investigated as a method of synthesising 
the aldehyde (88). (See Scheme 21.) The epoxide was formed in a 52% 
yield by reacting the acetophenone (84) with Corey’s sulphonium 






The Robinson annulation of the aldehyde (88) with methyl vinyl 
ketone was performed using benzyl trimethyl ammonium hydroxide 
(Triton B) as the base in t-butanol. The mechanism of the reaction
-2 3 -
(see Scheme 22) involves a Michael type addition, followed by an aldol 
condensation.
Scheme 22
CHO B ) CHO r —









Hydrogenation of the cyclohexenone (89), over a palladium on 
charcoal catalyst in glacial acetic acid, gave the cyclohexanone (76) in 
a 65% overall yield for the two steps.
-2 4 -
2.2.2 The Chiral Alkylation of the Cyclohexanone (76)
Of the various methods suitable for chiral alkylation of the 
cyclohexanone (76),30 the method of Enders,26 utilising the chiral 
hydrazone derived from (S )-l-amino-2-methoxymethylpyrrolidine 
(SAMP) was chosen. The Ender’s method has a good reputation, and 
high enantiomeric excesses have been reported for the alkylation of 
analogous compounds. It also has the advantage that the chiral 
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Hydrazone formation was a reasonably facile procedure, which 
entailed heating the cyclohexanone (76) and SAMP at 60° C, under 
argon, for 18 h. Purification by distillation gave the chiral hydrazone 
(93) as a colourless oil in 90% yield. The mixture of the two
-2 5 -
diastereomers produced gave rise to complicated *H n.m.r. and 13C 
n.m.r. spectra that could not be readily assigned. However, the mass 
spectrum of the isomers showed the expected mass ion peak at m/z 
330 and the elemental analysis fitted the required formula.
The chiral hydrazone (93) was then metalated using potassium 
diisopropylamide31 (KDA) in dry ether at -78° C. KDA reacts at a 
faster rate than lithium diisopropylamide (LDA). This is despite the 
fact that LDA can be used at 0°C, whereas KDA must be used at 
-78° C to avoid its decomposition. Even with KDA complete metalation 
was never achieved because of the slow rate of the reaction, possibly 
the result of steric hindrance. For practical reasons, it was only 
possible to keep the suspension at -78° C for 8 h before quenching. 
In the case of LDA, a gum was formed on stirring at room
temperature. Given a cold room with the necessary facilities, or a
cryogenic bath, it would presumably be possible to extend the
reaction time to ensure that complete metalation had occurred.
The reaction was quenched at -100° C, using an ethereal solution 
of methyl tosylate, and the temperature was maintained at -100 °C for
a further hour. Both low temperature2 6 and the use of a bulky
alkylating reagent3 2 have been shown to increase the enantiomeric
excess of the chirally alkylated product.
Enders’ chiral hydrazone method of chiral induction relies on 
one of the four possible conformers of the metalated hydrazone being 
more thermodynamically stable than the others. (See Figure 6.)
Electrophiles predominantly attack the metalated hydrazone from
below the CCNN plane (indicated by the black arrow). For
conformations A and D, this would mean that electrophilic substitution 
was occurring syn to the co-ordinated lithium (SEi), whereas
-2 6 -
F ig u re  6
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L i




conformations B and C would require an electrophilic substitution 
anti to the co-ordinated lithium. Inspection of molecular models (CPK, 
Dreiding) favours conformation A, which is in full agreement with the 
experimental results and calculations described by Enders.26
The CN double bond of the crude chirally alkylated hydrazone
(77), (mainly of a mixture of two stereo and two diastereomers: ERR; 
ERS; ZRR and ZRS), was then cleaved to give the chiral dimethyl- 
cyclohexanones, (78) and (79). This was effected by heating the 
hydrazone (77) in a pressure tube at 40°C with methyl iodide. The 
methiodide salt so formed was then hydrolysed directly in a biphasic 
system of n-pentane and 2.5 M hydrochloric acid. A mixture of the 
chiral dimethylcyclohexanones, (78) and (79), was obtained as a
-2 7 -
c o lo u rle s s  oil. (See Schem e 24.)
Scheme 24
N Mel, 40°C 





Chiral <x-alkylated ketones rapidly racemise in the presence of 
traces of base, but are more stable in the presence of acid. Biphasic 
acid hydrolysis therefore, minimises racemisation of the product. Low 
solubility of the acid in the n-pentane layer, in which the chiral 
dime thy Icy clohexanones, (78) and (79), accumulate, also aids in the 
prevention of racemisation. Previous studies26 had shown that no 
noticeable racemisation occurs in chiral ketones in this system over a 
period of 1 h.
A 40% recovery of the SAMP using this method was referred to 
by Enders26 as a part of a Ph.D. dissertation by Eichenauer,3 3 but 
no published description of the procedure is available. Our attempt 
involved basification of the aqueous phase, which contains the two 
salts, (95) and (96), followed by implementation of the steps illustrated 
in Scheme 7. The results were far short of those claimed by Enders.
As a consequence of the base sensitivity of the chiral dimethyl- 
cyclohexanones, (78) and (79), all glassware had to be acid washed
-2 8 -
F ig u re  7
OMe
O ^ '  < * >
x "  + I
'  NH2 N H +  X-
/ OH
(95)
NH2 H„0 + V.N [0]  ^
(97)
prior to use, in further work. Purification by column chromatography 
on silica gave the two separate diastereomers in a c i s/t rans ratio of 
1:3 and a combined yield of 61%. A diastereomeric excess (d.e.) of 96% 
was obtained for the tr an s-dimethylcyclohexanone (78), which was 
determined by gas chromatography and also from the -^H n.m.r. 
spectrum. If the chiral dimethylcyclohexanone (78) was undergoing 
epimerization on the silica during chromatography the d.e. would be 
expected to be substantially lower.
Hydrazone cleavage was also attempted using Enders’ standard 
conditions for the ozonolysis of the CN double bond. However, on 
distillation of the resultant product, decomposition took place leaving 
a black tar and very little of the desired product.
Determination of the enantiomeric excess of the t rans-dimethyl­
cyclohexanone (78) was made using the chiral solvating agent 
(-)-l-(9-anthryl)-2,2,2-trifluoroethanol (TFAE) in a 1H n.m.r. 
experiment. Racemic t rans-dimethylcyclohexanone (78) was used as a 
control. The racemate was prepared by performing a Robinson 
annulation on the aldehyde (88) using ethyl vinyl ketone (EVK) and
-2 9 -
then hydrogenating the methylcyclohexenone (98) over palladium on 









The enantiomeric excess of the t rans-dimethylcyclohexanone
(78) was found to be 76% (±2%). Unfortunately, the chiral solvating 
agent did not resolve the peaks in the *11 n.m.r. spectrum of the 
racemate of the ci s-dimethylcyclohexanone (79). Consequently it was 
not possible to measure the enantiomeric excess until the oxime of the 
c i s-dimethylcyclohexanone (101) had been synthesised. No decrease in 
the enantiomeric excess was observed on the formation of the 
t rans -oxime (102); therefore it may be reasonably assumed that the 
same is true for the formation of the cis-oxime (101). This being the 
case, the enantiomeric excess of the ci s-dimethylcyclohexanone (79) 
can be deduced to be the same as that of the cis-oxime (101) (60 ± 
4%) using the chiral solvating agent TFAE (see Chapter 2.2.3).
The difference in the enantiomeric excesses of the two 
diastereomers can be explained by the difference in the relative 
conformational energies of the metalated hydrazone (see Figure 6),
-3 0 -
depending on whether the aromatic ring occupies a pseudo-axial or a 









Assignment of the 1H n.m.r. spectra of the cis- and 
t rans -dimethylcyclohexanones, (79) and (78), was made with the aid 
of n.O.e. studies, and from the spin-spin splitting patterns and 
associated coupling constants. (A brief discussion of the factors 
involved is given in the next chapter in the assignment of the c i s -  
and trans-oximes, 101 and 102.) The appearance of the resonance of 
the 3-H proton as a triplet means that it has two large coupling 
constants, one geminal and one vicinal-diaxial, and thus the 3-H 
proton must be axial with respect to the ring. In the spectrum of the 
t rans-dimethylcyclohexanone (78) the resonance of the 5-H axial 
proton is clearly visible adjacent to the resonance of the 3-H proton. 
It is seen as a triplet of doublets, with two large coupling constants 
and one smaller coupling constant. Occurring at an analogous position 
in the ring to the 3-H proton, the resonance of the 5-Hax proton has 
a similar chemical shift and splitting pattern.
In the case of the c i s-dimethylcyclohexanone (79), irradiation 
of the 4-CH3 resonance at 8 1.59 ppm led to an enhancement of the 
resonances of the 2-Ha x and 6-Ha x protons, providing evidence that 
the 4-CH3 group is in an axial position on the cyclohexanone ring
-3 1 -








and f ran  s-dimethylcyclohexanones, (79) and (78), at 8 1.0 ppm,
resulted in an enhancement of the resonances of the 2-Ha , 3-Ha 
and 3-Heq protons, which suggests that the 2-CH3 group occupies an 
equatorial position in both compounds. If the 2-CH3 were in an axial 
configuration, an enhancement of the 2-Heq, 6-Hax and 3-Heq protons 
would be expected. (An X-ray crystallographic determination of the 
c i s-dimethylcyclohexanone oxime (101) confirmed the above 
configurational assignment.)
The chiral alkylation was also performed on the cyclohexenone 
(89) (see Figure 10), which gave a poor yield, but the same 
enantiomeric excess. However, separation of the two diastereomers 
proved impossible for the dimethylcyclohexenones (103).
Figure 10
OMe (89) OMe (103)
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2.2.3 The Beckmann Rearrangement
The two diastereomers of the chiral dimethylcyclohexanone, (78) 
and (79), were converted into their respective oximes immediately 
after isolation, in order to minimise racemisation. Oxime formation was 
performed by stirring the dimethylcyclohexanones, (78) and (79), with 
hydroxylamine hydrochloride and sodium acetate in aqueous methanol 
at room temperature for 24 h. The oximes, (101) and (102), were
Figure 11
OH
OMe ( 101) OMe ( 102)
obtained as colourless crystalline solids in 85% yield after 
recrystallization. From a -^H n.m.r. experiment using the chiral 
solvating agent TFAE, the enantiomeric excess of the t rans -oxime 
(102) was determined to be 76% (±2%). This means that the amount of 
racemisation taking place during the oxime formation was negligible. 
Using the same technique, the enantiomeric excess of the cis-oxime 
(101) was determined to be 60% (±4%).
In both cases the oximes, (101) and (102), were found to consist 
solely of their E-isomers with respect to the CN double bond. The 
reason for this E-selectivity is presumably that the methyl group at 
C-2 occupies an equatorial position in both cases (see Figure 12). 
Therefore the Z-oximes would experience an unfavourable steric 
interaction between the hydroxy group and the 2-CH3 group.
The structure of the cis-oxime (101) was confirmed by X-ray 
crystallography. (See Figure 13.)
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Assignment of the 1H n.m.r. spectra of the two oximes was made 
on the basis of the spin-spin splitting patterns and associated 
coupling constants. In a cyclohexane chair conformation the coupling 
constants between the adjacent protons can be roughly calculated 
using the Karplus equation, which relates the size of the coupling 
constant to the dihedral angle (see Figure 14).
The coupling constant of two geminal protons and that of two 
adjacent axial protons will tend to be large (J - 10-15 Hz), whereas 
the coupling constant of one axial proton and an adjacent equatorial 
proton are usually medium to small in value (J * 5 Hz). The smallest 
coupling constant is that between two adjacent equatorial protons (J 
= 0-3 Hz).
For the t r a n s -oxime (102) the resonance of the H-3 axial proton 
has two large coupling constants (one geminal and one vicinal diaxial) 
giving a "triplet” at 6 1.43 ppm, J = 13.3 Hz. The resonances of the 
H-5 axial and H-6 axial protons occur as two quartets of doublets,
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F ig u re  14
Hax J a 1 , e 1 = l a r 9® (geminal)
Ja2,e2 = l a r 9e (geminal)
J a l , a 2  = l a r 9e
J a i , e 2  «< J e i , a 2  = medium-small 
J a 0 = smalle 1 ,  e 2
with two large coupling constants (one geminal and one vicinal diaxial) 
and one smaller coupling constant (a vicinal axial-equatorial coupling) 
at 5 1.82-1.49 ppm. Resonances for the H-2 axial proton and the two 
H-5 and H-3 equatorial protons are multiplets lying at 8 2.38-2.20 and 
8 2.50-2.38 ppm respectively. The resonance due to the H-6 equatorial 
proton occurs at relatively low field, 8 3.27 ppm, as a doublet of
triplets, J = 14.1 and 2.8 Hz. Presumably this proton is being
deshielded by the electronic effect of the oxygen atom, which lies 
comparatively near in space (2.29A calculated from the X-ray data for 
the cis-oxime, 101).
The 1H n.m.r. of the cis-oxime (101) is similar to that of the 
trans -compound, except that the resonances of the H-3 equatorial, 
H-6 axial and H-5 protons now all overlap and are seen as a multiplet 
at 8 2.10-1.75 ppm.
A n.O.e. study on the t  r a n s-oxime (102), irradiating the 
exchangeable resonance of the OH proton at 8 9.3 ppm, gave signal 
enhancements for the methyl group at C-2 of 4.1%; the H-2 axial 
proton of 0.7% and the H-6 axial proton of 1.2%. This apparently 
contradictory evidence for the E/Z -configuration of the oxime is 
explained by looking at the X-ray structure of the cis-oxime (101). 




it can be seen that the distance between the nitrogen and oxygen 
atoms in the oxime functionality in adjacent molecules (2.79A), is less 
than the combined Van der Waals radii of the oxygen and nitrogen 
atoms (2 .90A).34 This observed distance of 2.79A implies that the 
oxime is hydrogen bonded and agrees with the intermolecular 
distances found in other known examples of hydrogen bonded 
oximes.34 The absorption of the hydroxy group in the infrared 
spectrum occurs as a broad peak at 3250 cm*1, which is again 
indicative of hydrogen bonding.
Figure 15
n.O.e.  e f f e c t
Hydrogen bonding would lead to the geometry seen in Figure 
15, where the proton of the oxime hydroxyl is relatively near in space 
to the methyl group at C-2 on the neighbouring molecule, which would 
account for the magnitude of the n.O.e. obtained. It is possible that 
when in solution, the oxime exists in a dimeric form similar to that 
encountered in carboxylic acids.
The Beckmann rearrangement involves the rearrangement of an 
oxime to an amide. The hydroxyl group is converted to a leaving 
group and the alkyl group trans to the modified hydroxyl group 
migrates to the nitrogen atom displacing the leaving group. This 
leaves a positive charge on the carbon atom, which is rapidly 
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Perez and Fernandez35 have shown that it is possible to effect 
the rearrangement of the oxime (107) to the amide (108) without 
racemisation (see Scheme 27). The reagent used was phosphorus 
oxychloride/pyridine and it is noteworthy that the bulky isopropyl 






Perez and Fernandez found that by reacting the chiral oxime 
(107) with phosphorus oxychloride in pyridine at 0°C,36 the only 
observed product was the caprolactam (108). The bulky isopropyl 
group led to the sole formation of the E-isomer, which in turn gave 
rise to the single caprolactam isomer produced under the above
-3 8 -
conditions.
By applying this procedure to the trans- and c i s-dimethyl- 
cyclohexanones, (78) and (79), the respective caprolactams, (109) and
70-80% yields after recrystallization.
1H n.m.r. studies, using the chiral solvating agent TFAE, 
showed that no racemisation had occurred in the formation of the 
t r ans -caprolactam (109). Indeed, the enantiomeric excess was 
improved by means of the recrystallization.
Assignment of the *H n.m.r. was made with the aid of an 
irradiation study. In the case of the trans-caprolactam (109), 
irradiation of the resonance of the H-7 proton, a multiplet at 8 3.48 
ppm, led to the collapse of a doublet of doublets at 8 1.58 ppm to a 
doublet, showing that this signal was the resonance of one of the H-6 
protons. Irradiation of a signal at 8 1.58 ppm caused the doublet 
under the multiplet at 8 2.48 ppm to collapse to a singlet, revealing it 
to be the resonance of the other H-6 proton. The resonances of the







final four protons in the caprolactam ring were assigned on the basis 
that the H-3 protons occur at a lower field due to the deshielding 
effect of the adjacent carbonyl group of the amide. Thus the 
resonances of the remaining three protons in the multiplet at 6 2.4 
ppm may be assigned to the two H-3 protons and one of the H-4 
protons. Finally, the multiplet at 8 1.66 ppm was assigned to the
resonance of the other H-4 proton. Since the resonances of H-4 and 
H-6 occur at similar chemical shifts, they may be on the same face of 
the caprolactam ring.
An alternative method for the Beckmann rearrangement, which 
involved heating the cyclohexanone with hydroxylamine-O-sulphonic 
acid in formic acid37 gave an inseparable mixture of the two possible 
regioisomers, (111) and (112). This can be explained by the 
equilibrium between the E- and Z-isomers that is known to take place 
in acid conditions38 leading to the rearrangement of the Z- as well as 


















2 .2 .4  W -P rotection  an d  R ing O p en in g  o f  th e  C aprolactam  (110)
When considering the protecting group for the caprolactam, we 
were looking for a group that fulfilled two primary conditions. These 
were that it would not be attacked preferentially by alkyl lithium 
reagents in the amide cleavage step and also that it would be easily 
removed at the end of the synthesis.
In our initial studies we investigated carbamates as possible 
protecting groups, relying on the more reactive nature of the amide 
carbonyl compared to that of the carbamate to give the required 
selectivity on ring opening. Benzyl chloroformate was reacted with the 
c i s-caprolactam (110) using a variety of conditions to give the 
benzylcarbamate derivative (113) in varying yields. The best results 
were obtained by stirring a solution of the c i s-caprolactam (110) in 
tetrahydrofuran, with sodium hydride, at room temperature for 1 h 
and then heating the resultant solution under reflux conditions for 8 
h. Using this method the benzylcarbamate derivative (113) was 
obtained in 49% yield, with a 19% recovery of starting material.
Figure 17
By way of comparison the c i s -caprolactam (110) was stirred 
with sodium hydride at room temperature, in tetrahydrofuran, for 1 h 
and then treated with benzyl bromide. After stirring at room 
temperature for 16 h the benzylcaprolactam (114) was obtained in 51% 
yield, together with a 25% recovery of starting material. By employing 
identical reaction conditions, but this time using methyl iodide to
0
R
R = H (110), C02CH2Ph (113), 
CH2Ph (114) and CH3 (116).
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quench the amide anion formed, the methylcaprolactam (116) was 
isolated quantitatively. When this reaction was repeated on the 
trans -caprolactam (109), it was found that the initial deprotonation of 
the amide required 24 h to reach completion. However, on quenching 
with methyl iodide the yield was also quantitative.
As a consequence of these results, we decided to use a methyl 
group as the protecting group for the ring opening reaction. 
Deprotection of A/-methyl derivatives of various opioid derivatives are 
well documented in the literature. Reagents in common use for this 
reaction include cyanogen bromide and several chloroformates.
The carboxamide anion involved in the alkylation/acylation of 
amides under basic conditions3 9 possesses two centres at which 
electrophilic attack is possible. (See Scheme 29.)
Scheme 29
Alkylation/acylation can take place at either the oxygen or the 
nitrogen atom. In practice, the alkylation of primary and secondary 
amides in the presence of strong base normally occurs at the nitrogen 
atom. In the presence of silver salts and also by using alkyl 
diphenyl sulphonium salts, the O-alkylated products predominate.40 
Acylation of amides under neutral conditions is thought to proceed 
via an O-acylated intermediate41 to give the W-acylated product. (See 
Scheme 30.) However, under the basic conditions used, acylation 
probably involves direct attack of the nitrogen anion, as is the case 
for alkylation.42




compounds can be attributed to steric factors influencing the 
attacking electrophiles. The fact that the amide is being fully 
deprotonated by the sodium hydride is evident from the quantitative 
yields obtained when quenching with methyl iodide.
The *H n.m.r. spectra of the trans- and cis-m ethyl- 
caprolactams, (115) and (116), show the resonance of the A/-methyl 
protons as a singlet at around 6 2.9 ppm and the disappearance of 
the resonance of the exchangeable N-H proton at around 8 6.1 ppm. 
These spectra were assigned with the aid of two dimensional COSY-90 
1 H n.m.r. experiments.
Ring opening of the caprolactam was performed by adding 
methyl lithium, at 0°C, in dry tetrahydrofuran. Methyl lithium attacks 
the amide carbonyl group to give a tetrahedral intermediate which 
then collapses to give the aminoketone when quenched in aqueous 
acid. (See Scheme 31.) In the case of the ci s-methylcaprolactam (116), 
this gave the methylaminoketone (117), in a 53% yield, as a yellow oil, 
which was relatively unstable in air and decomposed on silica. When 
the reaction mixture was quenched with trifluoroacetic anhydride, the 
trifluoroacetamidoketone (81) was isolated in 55% yield, as a pale 
yellow waxy solid, with a 13% recovery of starting material.
Only one equivalent of methyl lithium was used, in order to 
minimise over reaction which could occur if a second molecule of 
methyl lithium attacked the carbonyl centre. This side reaction would 













product when methyl Grignard reagents are added to A/-methyl- 
caprolactam.4 3 Increasing the amount of methyl lithium added did 
indeed lead to a decrease in yield, however, the dimethyl compound 
was not isolated.
The change in functionality from amide to aminoketone can 
clearly be seen by comparing the IR spectra of the methylcaprolactam 
(116) and the aminoketone (117), in which the absorption peak of the 
carbonyl changes in wavenumber from 1640 cm"* to 1695 cm-1 . These 
values are typical for the carbonyl absorption of a seven membered 
lactam and an aliphatic ketone respectively. The change in 
functionality is also visible in the *11 n.m.r. spectrum of the methyl 
amino ketone (117) in which the appearance of a singlet at 6 2.03 ppm 
(due to the resonance of the H-l protons) reveals the presence of the 
methyl ketone. An upfield shift of the A/-methyl resonance from 6 2.90 
ppm in the starting material to 6 2.25 ppm in the product also
illustrates the change from amide to amine functionality of the 
nitrogen atom.
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The 1H n.m.r. spectrum of the trifluoroacetamidoketone (81) is 
complicated by the fact that it is present as a 1:9 mixture of 
rotomers. This made precise assignment of all the proton resonances, 
and also of the 13C n.m.r. spectrum, impossible. However, the 
compound analysed correctly and the two carbonyl peaks of the 
ketone (1710 cm-1 sh) and the trifluoroacetamide (1680 cm-1 ) were 
clearly visible in the lit spectrum.
Ring opening of the benzylcaprolactam (114) with methyl lithium 
gave only an 8% yield of the benzylaminoketone (118) and a 75% 
recovery of starting material. This low yield may be attributed to a 
complex induced proximity effect as described by Meyers and Beak.44 
(See Scheme 32.)
Selective benzylic deprotonation is in competition with the 




2.2.5 The Cyclodehydration Reaction
Standard reaction conditions, which consisted of heating the 
aminoketone (117) with polyphosphoric acid at 120°C for 5 minutes,45 
were employed to begin with. This method, however, gave only a 10% 







40% recovery of starting material. Presumably the poor yield seen 
here is due to decomposition of the sensitive aminoketone (117). A 
milder set of conditions, where the sample is heated in a solution of 
dioxane with a few drops of concentrated hydrochloric acid, was used 
by Jackson et a i . 46 in his modification of the Pomerantz-Fritsch 
isoquinoline synthesis. By heating a solution of the aminoketone (117) 
in dry dioxane with a few drops of concentrated hydrochloric acid at 
70° C for 6 h, the required dihydronaphthalenethanamine (119) was 
obtained in 61% yield.
The n.m.r. spectrum clearly shows that the aromatic ring
system of this product had changed from being 1,3-disubstituted to 
1,2,4-trisubstituted and also shows the appearance of the resonance 
for the alkenic proton H-3’ at 6 5.62 ppm. The pattern of the
resonances for the aromatic protons had changed from two triplets 
and two doublets of doublets to two doublets and a doublet of 
doublets. Proton resonances were assigned with the aid of a two 
dimensional COSY-90 1H n.m.r. experiment. Coupling was observed 
between the resonance for the alkenic proton H-3’ and that of the two
-4 7 -
H-2’ protons (a multiplet at 6 2.22 ppm). The resonance of the two 
H-l protons occurs at 8 1.55 ppm as an ABX quartet, JAB - 14.2 Hz 
and J a x  ~ J b x  = 4*9 Hz, and is coupled to a multiplet at 8 2.47 ppm, 
which is due to the resonance of H-2. A broad, exchangeable, singlet 
at 8 1.17 ppm is assigned to the resonance of the amino N-H proton.
The proposed mechanism for the cyclisation reaction involves an 
initial protonation of the ketone followed by an aromatic electrophiiic 
substitution reaction exclusively at C-6 of the aromatic ring. 
Subsequent dehydration of the alcohol formed gives the conjugated 







is possible at C-2 of the aromatic ring, but presumably this reaction 
is disfavoured on steric grounds.
When this reaction was repeated on the trifluoroacetamidoketone 
(81), the conditions were changed slightly to ensure that the 
trifluoroacetyl group was not hydrolysed. Moisture was kept to a 
minimum in the reaction, which was carried out in a solution of
-4 8 -
hydrogen chloride in dry dioxane. The only source of water was from 
the dehydration reaction of the intermediate, which was not enough to 
cause the hydrolysis of the trifluoroacetamide function to any 
appreciable extent. The trifluoroacetyl dihydronaphthalenethanamine 
(120) was obtained in 63% yield, as a colourless crystalline solid (87% 
based on recovered starting material). *H n.m.r. revealed that the 
compound was present as a 1:4 mixture of rotomers. This mixture of 
rotomers again made assignment of the 13C n.m.r. spectrum 
impossible. However, all other data are in agreement with the 
proposed structure, which was confirmed by X-ray crystallography 
(see Figure 19). (A list of bond lengths and angles, as well as the 
fractional atomic coordinates are given in Appendix A.)
From the X-ray structure it can be seen that the carbonyl 
group lies over the benzene ring. Initially we proposed that this was 
due to a tt-stacking effect, however after calculating the distance and 
angle of the carbonyl from the plane of the benzene ring (C15-Ar = 
3.42A, 0 2-Ar = 3.22 A and the angle between carbonyl plane and 
aromatic plane = 27 .6° ) ,  using a least squares method, we found no 
positive evidence to prove that what we were witnessing was not 
purely due to crystal packing. (For details of the least squares 
calculation see Appendix A.)
-4 9 -  
Figure 19
2 .2 .6  T he Chromium C om plexation R eaction  an d  F ina l R ing C losu re
Initially, our intention was to make use of a reaction originally 
described by Knox et a I.4 7 and subsequently investigated by 
Semmelhack et a i . 48 and Uemura et a i . 49 (see Scheme 34), to 




CO ”  <122>
E = H, Me and PhCO
This reaction makes use of the stabilizing effect of the 
chromium tricarbonyl unit upon benzylic anions5 0  (see Figure 20), 
which is exerted as a result of its electron withdrawing properties. 
The chromium tricarbonyl unit also controls the directional approach 









We proposed that after forming the chromium complex of the
-5 1 -
dihydronaphthalenethanamine (123), it would then be possible to 
perform the ring closure reaction via the anion of the amino group. 
Chromium complexation should be selective to the least sterically
group. Any attacking electrophile would come from the face opposite 
the chromium tricarbonyl moiety, thus controlling the stereochemistry 
at C-l of the benzomorphan (83).
Usual conditions5 2  were employed for the chromium 
complexation, which entailed heating chromium hexacarbonyl and the 
substrate, under reflux, in a solution of tetrahydrofuran/di-n-butyl 
ether (1:9), for 48 h. Complexation of the dihydronaphthalenethanamine 
(119) gave rise to an amount of black tar, as well as the required 
chromium tricarbonyl complex. The black tar is an indication that 
polymerisation is occurring. Polymerisation during complexation has 
long been known as a side reaction for styrenes and dihydro­
naphthalenes53, and various methods have been used to avoid it . 5 4






No such polymerisation was observed in the complexation of the 
trifluoroacetyl dihydronaphthalenethanamine (1 2 0 ), indicating that it 
was the presence of the unprotected amino group that was causing 
the problem, rather than polymerisation of the dihydronaphthalene 
moiety per se. (Polymerisation was not expected in this case due to 
the sterically hindered nature of the double bond.)
The dihydronaphthalenethanamine (119) gave rise to a 2:1 
mixture of trans- to ci s-chromium complexes as an orange oil in 24% 
yield. These two isomers were not separable by column 
chromatography and were extremely air and light sensitive. This 
result should be compared to the complexation of the trifluoroacetyl 
derivative (120), which gave the required product as a 9:1 mixture of 
trans- to ci s -complexes. These two isomers were separated by 
column chromatography and isolated as orange solids in 36% and 4% 
yields respectively. (Starting material was also recovered in a 58% 
yield.)
Stereoselective control of chromium complexation has been 
demonstrated by Davies et a I . 5 5 using the 1-isopropyltetrahydro- 
isoquinoline (124) (see Scheme 36), where the sole product from the 
complexation is the trans-compound. It was also shown by Davies et 
a 1. 5 5  that for 1 -hydroxytetrahydronaphthalene (126) only the 
cis -isomer is obtained upon complexation. (A mechanism involving 
initial chelation to an oxygen lone pair, followed by delivery to the 
proximate face has been cited for the latter reaction.56) This guiding 
effect may explain why the selectivity in the complexation reaction of 
the dihydronaphthalenethanamine (119) is only 2:1, since the steric 
and electronic factors are now competing with each other. The 
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in which the lone pair is much less readily available, is 9:1 in favour 
of the t rans -complex.
Measurement of the c i s:t rans ratio was determined by 
comparing the chemical shifts of the methyl groups at the 1 ’-  and
2-positions, in the 1H n.m.r. spectra. Examination of the 1H n.m.r.
-5 4 -
spectra of analogous compounds in the literature reveals that the 
chromium unit exerts a small deshielding effect on any groups
situated on the same face of the molecule. This downfield shift in
signals for groups on the same face as the chromium moiety is only
visible when the c i s -  and trans-complexes are compared (see Figure
2 1 ) .
Of the seven applicable examples found , 4 9 * 5 5  * 5 7  all exhibited 
this deshielding effect. The configuration of these structures were 
determined by X-ray crystallography or were based on the fact that 
the chromium group had been used to control stereochemistry in their 
synthesis . 5 7 c
The 1H n.m.r. spectrum of the dihydronaphthalenethanamine 
chromium tricarbonyl complex (123) clearly showed the upfield shift in 
the aromatic protons caused by the chromium atom, where the signals 
for the resonances of these three protons were now occurring at 8  
5.69-5.12 ppm (normally these protons resonate at 8  7.21-6.69 ppm), 
together with the signal for the alkenic H-3’ proton. As in all the 1H 
n.m.r. spectra of the chromium complexes taken, the signals were 
broadened by the presence of small amounts of paramagnetic 
chromium(III) species, which occur as impurities; this made precise 
assignment impossible. It was however, possible to assign the major 
peaks observed. The chemical shifts of the resonances for the N-CH3, 
l ’-CH3 and H-3 methyl groups for both the isomers are listed in Table 
1 .
From this table it can be seen that the resonance of the methyl 
group H-3 occurs at a lower field for the minor isomer, whereas the 
resonance for the methyl group l ’-CH3 occurs at lower field for the 
major isomer. These observations, if taken in the context of the trend
-5 5 -
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() = chemical s h i f t ,  5 ppm
shown in Figure 21, suggest that the major isomer is the 
t ran s -complex, while the minor isomer is the cis -complex.
In the case of the trifluoroacetyl derivative, the c i s -  and 
t ran s -complexes, (130) and (82), were separable by column
-5 6 -





CHEMICAL SHIFT (8) ppm
MAJOR ISOMER MINOR ISOMER
n- ch3 2 .28 2 .17
l'-C H 3 1.47 1 .16
H-3 0 .72 0 .90
chromatography and the stereochemistry of chromium in the 
trans -complex was apparent by virtue of the stereochemistry of the 




CHEMICAL SHIFT (8) ppm
TRANS CIS
n- ch3 2 .63 3 .05
i ' - ch3 1 .4 4 1 .12
H-3 1 .08 1.31
Assignment of the 1H n.m.r. spectrum of the trans -complex (82)
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was based on irradiation studies and also by comparison to the 
spectrum of the uncomplexed trifluoroacetyldihydronaphthalen- 
ethanamine (120). This clearly shows the alkenic resonance for H-3’ at 
6  5.66 ppm as a doublet, J - 6  Hz, lower field than the aromatic
protons, the signals of which lie at 6  5.58 and 5.17 ppm. The alkenic 
resonance is coupled to the signal for one of the H-2’ protons, a 
doublet of doublets, J - 7 and 17 Hz, at 6  2.09 ppm. Of the aromatic 
protons it is the H-5’ proton resonance which appears lowest field at 
6  5.58 ppm and is recognizable as a doublet with a coupling constant 
of J = 7 Hz. The signal at 6  5.17 ppm is a multiplet combining the 
resonances of both the H-6 ’ and H-7’ protons.
The cyclisation reaction was attempted on both the amino (123) 
and trifluoroacetamido (82) complexes. t-Butyl lithium was added to a 
solution of the amino derivative at 0°C, to deprotonate the amine 
function. Ammonium chloride solution was then added at -78° C to 
quench the reaction. After the reaction had been allowed to warm to 
room temperature, it was worked up to afford only starting material. 
A bulky base was used to deprotonate the amine in order to try  to 
reduce the chance of the base directly attacking the double bond.
For the trifluoroacetamido complex (82), methyl lithium was 
added at -78°C, with the intention that it would preferentially attack 
the carbonyl group of the trifluoroacetamide to form a tetrahedral 
intermediate, which would collapse to give the nitrogen anion and 
trifluoromethyl methyl ketone. A solution of dimethyl disulphide was 
then added at -78° C, to trap any ring closed anion that had formed. 
The only compounds isolated from this reaction were starting material, 
the amino complex (123) and a small amount of the acetamido complex
(131). The presence of the acetamido product indicates that the
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tetrahedral intermediate is also collapsing to give a trifluoromethyl 
anion, to a smaller extent.
Alkylation of a dihydronaphthalene chromium tricarbonyl complex 
has been described by Semmelhack et a I . , 4 8 using a stabilised anion 
(see Scheme 34). When the reaction was quenched with ammonium 
chloride solution at temperatures between -78°C and 25°C, only the 
addition product (122, E = H) was observed. However, when methyl 
iodide was used to quench the reaction, a mixture of starting material, 
the addition product (122, E = H) and the required addition product 
(122, E = Me) were obtained. Quenching at 25° C gave only starting 
material, while quenching at -78° C gave a 1:2:6 mixture of starting 
material, the protonated addition product (122, E = H) and the 
methylated addition product (122, E = Me). When the reaction was 
quenched at 0°C, a 4:1 mixture of the protonated and methylated 
products was obtained. Semmelhack proposed that the initial attack by 
the lithium dimethylacetonitrile was an equilibrium process. The 
equilibrium was assumed to lie well over towards the side of addition 
product anion. At higher temperatures the equilibrium was rapid 
enough to produce a sufficient concentration of the dimethyl­
acetonitrile anion to allow the methyl iodide to react selectively with 
it.
Initially we thought that the failure of our ring closure reaction 
was due to this type of equilibration, which was heavily in favour of 
the ring opened anion (see Scheme 35). In order to try  and 
selectively quench the ring closed form, dimethyl disulphide was used 
to quench the reaction. It was proposed that weak nature of the 
sulphur-nitrogen bond would preclude the quenching of the nitrogen 
anion before ring closure was achieved. Unfortunately, this attempt
also proved unsuccessful. One explanation may be that the anion of 
the amino group is complexing to the chromium in an intermolecular 
fashion, thus preventing further reaction (see Figure 23).
Figure 23




To circumvent this problem, the ring closure reaction was 
attempted using potassium carbonate in aqueous methanol as the base, 
and treating the resultant mixture with ultrasound. Using potassium 
carbonate avoids any chance of the reverse reaction occurring, 
because any ring closed intermediate formed immediately picks up a 
proton. The conditions used had previously been applied to the 
uncomplexed trifluoroacetyl dihydronaphthalenethanamine (1 2 0 ) to 
hydrolyse the trifluoroacetyl group and had given the deprotected 
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dihydronaphthalenethanamine chromium complex (82), as well as 
hydrolysing the trifluoroacetyl group, the conditions slowly gave rise 
to the ring closed product (133). After 72 h, the ring closed product 
was isolated, decomplexed and purified by preparative thin-layer
-6 0 -
chromatography to give the hexahydro-2,6-methano-3-benzazocine (83) 
in 40% yield (based on recovered starting material).
Decomplexation was performed by dissolving the complex in 
ether and standing the solution in a sunny position, in the presence 
of air, for 24 h.
The 1H n.m.r. spectrum of the hexahydro-2,6-methano-3-benz- 
azocine (83) was assigned with the help of a two dimensional COSY-90 
experiment. The resonance of the proton H-l at 6  3.12 ppm is seen as 
a broad quartet, J =7.1 Hz, and is only coupled to the signal for the
1-CH3 group, which occurs as a doublet, J = 7.1 Hz, at 6  1.22 ppm. 
No coupling is observed with H-2, which corresponds to a dihedral 
angle of 80-90° (according to the Karplus equation), revealing that 
the methyl group at C-l is in the a-configuration . 5 8 The proton 
resonance of H-2 is visible as a broad triplet, J = 3.1 Hz, at 6  2.88 
ppm and is coupled to the signals for the H -ll protons at 6  1.97 and 
1.69 ppm. These are observed as a doublet of triplets, J = 2.6 and
12.6 Hz, and a doublet of doublet of doublets, J = 1.1, 3.8 and 12.6 
Hz, respectively. (The further splitting present in these signals is 
probably due to a long range W-effect.) The resonance of H-4 occurs 
as a multiplet at 6  2.07 ppm and is coupled to the signal for the 
methyl group, 4-CH3, a doublet, J = 6.2 Hz, at 6  0.92 ppm, and the
Figure 25
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resonance for the two protons, H-5, which is obscured by the signal 
for the methyl group, 6 -CH3, at 8  1.35 ppm. The methyl group, 4-CH3, 
is confirmed as being in the a-position by its chemical shift. If it was 
in the P-position it would be expected to occur at higher field ( 8  
0.4-0.5 ppm) 5 9  due to the shielding effect of the aromatic ring over 
which the methyl group would be positioned.
The 13C n.m.r. spectrum shows signals for all the resonances of 
the required carbon atoms; however two of these signals are 
coincident. These are the signals relating to either C-2 or C-4, and 
C-5, which show up as single peak at 8  50.1 ppm. In the DEPT 90 
spectrum this signal is observed as a positive peak and in the DEPT 
135 spectrum it is seen as a negative peak. An off resonance 13C 
n.m.r. spectrum confirmed this conclusion, showing the signal at 8  
50.1 ppm as an overlapping doublet and triplet.
Mass spectroscopy revealed the mass ion, m/z 259 (M+, 20%), 
and the fragment ion, m/z 244 (100, M-CH3).
Optical rotation studies showed that the compound was 
laevorotatory, thus confirming the absolute configuration of the 
compound. 6 0  Enantiomeric excess was determined to be 8 6 % by 1H 





Chemicals, solvents and reagents were purified and dried, 
where appropriate, before use by standard methods. Preparative 
column chromatography6 8 was normally carried out on silica gel 60 
GF7736 or 9385 (E. Merck), or on alumina (Camag, Fisons 100-250
mesh). Thin-layer chromatography (t.l.c.) was carried out routinely on 
silica gel 60 GF254 (E. Merck). Proton (1H n.m.r.) and Carbon-13 (13C 
n.m.r.) nuclear magnetic resonance spectra were recorded at 270 MHz 
and 6 8  MHz respectively, in deuteriated chloroform solution, unless 
stated otherwise, on a JEOL FX270 instrument. Chemical shifts are 
expressed in p.p.m. (8 ) downfield from tetramethylsilane (TMS) as 
standard and coupling constants (J) in Hertz (Hz). Ultra-violet/visible 
spectra (U.V.) were recorded for 95% ethanolic solutions on a 
Perkin-Elmer Lambda-3 spectrophotometer. Infrared (I.R.) spectra were 
measured on a Perkin-Elmer 1310 instrument. Mass spectra (M.S.) were 
recorded on an A.E.I. MS12 mass spectrometer using E.I. at 70 eV 
unless otherwise stated. Mass to charge ratios are quoted and their 
relative intensity (%) are enclosed in parentheses. Normally, where 
solvents had to be removed, a rotary evaporator operating at 
water-pump pressure was employed. (Exceptions to this routine are 
noted.) Where solutions were degassed, the freeze-pump-thaw method 
was used. When ether is mentioned, it is always diethyl ether that it 
refers to. Enantiomeric excess was determined by 1H n.m.r. using the 





Sodium (46 g, 2.0 mol) was added portionwise to absolute 
ethanol (750 cm3) being stirred at 0°C under a nitrogen atmosphere 
over a period of 4 h. The mixture was stirred at room temperature for 
1 2  h, to ensure that all the sodium had dissolved, before being cooled 
to 0°C again. A mixture of 3’-methoxyacetophenone (150.2 g, 1.0 mol) 
and ethyl chloroacetate (245.1 g, 2.0 mol) in benzene (250 cm3) was 
added at 0°C over a period of 1 h. The resultant mixture was stirred 
at 0°C for 1 h and at room temperature for a further 3 h. The 
reaction mixture was quenched by adding it to a slurry of ice ( 1 0 0 0  
g) and glacial acetic acid ( 1 0 0  cm3) and then extracted with 
dichloromethane (4x500 cm3). The organic portions were combined,
washed with saturated aqueous sodium bicarbonate solution ( 2 0 0  cm3), 
and then with saturated brine (100 cm3). The dried (Na2 S04) organic 
layer was evaporated under reduced pressure to give an orange oil. 
Distillation gave the title compound as a yellow oil (223.1 g, 94%). b.p. 
140-145° C at 0.1 mmHg. IR(neat) vmax 2980, 2920sh, 2820, 1730 (CO), 
1600sh, 1580, 1450, 1430, 1290, 1220, 1080, 1040, 860, 830, 790, 750 and 
700 cm"1; 1R n.m.r. (CDC13) 6 H (Isomer I) 7.20 (1 H, t, J 7.9 Hz, 5’-H), 
6.94-6.88 (1 H, m, 6 ’-H), 6.85 (1 H, t, /  2.6 Hz, 2’-H), 6.77 (1 H, ddd, J
7.9, 2.6 and 0.9 Hz, 4’-H), 4.24 (2 H, ABX3, J AB 10.8 Hz, JAx 7.3 Hz, 
JBX 7.2 Hz, OCH2 CH3), 3.76 (3 H, s, 0CH3), 3.34 (1 H, s, 1-H), 1.72 (3 
H, s, 2-CH3) and 1.31 (3 H, t, J 7.1 Hz, OCH2 CH3 ),8 h (Isomer II) 7.18 
(1 H, t, J 8.2 Hz, 5’-H), 6.94-6.90 (2 H, m, 2’- and 6 ’-H), 6.76 (1 H, 
ddd, J 8.2, 2.6 and 1.1 Hz, 4’-H), 3.90 (2 H, ABX3, JAB 14.3 Hz, 
j a x , b x  7 -1 Hz> OCH2 CH3), 3.78 (3 H, s, 0CH3), 3.59 (1 H, s, 1-H), 1.72 
(3 H, s, 2-CH3) and 0.92 (3 H, t, J 7.1 Hz, 0CH2 CH3); 13C n.m.r.
-6 4 -
(CDC13) 8 c (Isomer I) 166.8 (CO), 159.6 (3’-C), 141.7 ( l ’-C), 129.2,
117.3, 113.3 and 110.4 (4xAr-CH), 61.3 (2-C), 60.9 (1-C), 60.9
(OCH2 CH3), 54.7 (0CH3), 16.7 and 14.0 (2xCH3 ),8c (Isomer II) 166.6
(CO), 159.1 (3’-C), 138.6 ( l ’-C), 128.8, 118.5, 113.7 and 111.5 (4xAr-CH),
63.4 (2-C), 60.5 (0CH2 CH3), 60.4 (1-C), 54.9 (OCH3), 24.4 and 13.7
(2xCH3 ); MS(m/z) 236 (M*, 31%), 190 (8 ), 163 (100) and 162 (100).
Ethyl 2-hydroxy-3-(3-methoxypheny1)-3-butenoate (8 6 )
Concentrated sulphuric acid (3 cm3) was added dropwise to a 
stirred solution of the oxirane ester (85) (115 g, 0.49 mol) in ether 
(500 cm3) at 0°C. The solution was stirred at room temperature for 30 
min and then was washed with water (50 cm3), then saturated
aqueous sodium bicarbonate solution (2 x1 0 0  cm3), and finally saturated 
brine (50 cm3). The solution was dried (Na2 S04 ) and evaporated to 
give the title compound as an orange oil (95.9 g, 83%). b.p. 127-130°C 
at 0.1 mmHg. IR(neat) vmax 3500 (OH), 3000, 2950, 2850, 1740 (CO), 
1600, 1580, 1490, 1470, 1430, 1290, 1220, 1090, 1050, 920, 860 and 780 
cm"1; 1E n.m.r. (CDC13) 8 H 7.23 (1 H, t, J 8.0 Hz, 5’-H), 7.01-6.95 (2 
H, m, 6 ’- and 2’-H), 6.84 (1 H, ddd, J 8.0, 2.5 and 0.9 Hz, 4’-H), 5.49 
(1 H, s, 4-H), 5.44 (1 H, s, 4-H), 5.02 (1 H, s, 2-H), 4.26-4.06 (2 H, m, 
ABX3 Jab 10.7 Hz and JAXfBx 7A Hz* OCH2 CH3), 3.79 (3 H, s, 0CH3) 
3.44 (1 H, br s, OH) and 1.12 (3 H, t, J 7.1 Hz, OCH2 CH3); 13C n.m.r. 
(CDC13) 8 c 173.3 (CO), 159.3 (3’-C), 145.8 and 139.9 ( l ’-C and 3-C),
129.2 (Ar-CH), 119.3 (Ar-CH), 117.2 (4-C), 113.3 (Ar-CH), 112.6 (Ar-CH),
73.6 (2-C), 62.0 (OCH2 CH3), 55.1 (0CH3) and 13.8 (OCH2 CH3); MS(m/z) 
236 (W*, 43%), 163 (100, W-COOEt), 150 (25) and 135 (73); Analysis 
(Found: C, 65.9; H, 6.84, C1 3 H1 6 0 4  requires: C, 66.1; H, 6.84%).
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2-Hydroxy-3-(3-methoxyphenyl)-3-butenoic acid (87)
A mixture of the butenoate ester (8 6 ) (95.9 g, 0.41 mol) and 2 M 
aqueous sodium hydroxide solution (500 cm3), was stirred at room 
temperature for 12 h. The orange solution formed was extracted with 
dichloromethane (100 cm3) and the aqueous layer acidified to pH 2 
with concentrated hydrochloric acid. The aqueous layer was then 
extracted with dichloromethane (4x300 cm3), and the organic washings 
from the acid layer combined. This organic portion was washed with 
saturated brine (50 cm3), dried (Na2 S04) and evaporated under
reduced pressure to give the title compound as a yellow waxy solid 
(81.3 g, 96%). IR(neat) vmax 3400-2900br (acid OH), 1700 (CO), 1590 sh, 
1570, 1480, 1280, 1210, 1100, 1070, 1040, 910, 870, 780 and 680 cm '1; 1E 
n.m.r. (CDC13) SH 8.0-6. 6  (2 H, br s, CHOH and COOH), 7.19 (1 H, t, J
7.9 Hz, 5’-H), 6.99-6.94 (2 H, m, 2’-  and 6 ’-H), 6.81 (1 H, dd, J 7.9 and
2.0 Hz, 4’-H), 5.49 (1 H, s, 4-H), 5.41 (1 H, s, 4-H), 5.07 (1 H, s, 2-H) 
and 3.81 (3 H, s, 0CH3); 13C n.m.r. (CDC13) 8 C 176.5 (CO), 159.2 (3’-C),
144.9 and 139.4 ( l ’-C and 3-C), 129.3 (Ar-CH), 119.3 (Ar-CH), 117.7 (4- 
C), 113.4 (Ar-CH), 112.6 (Ar-CH), 73.2 (2-C) and 55.1 (0CH3); MS(m/z) 
208 (W + , 25%), 163 (25, tf-COOH) and 135 (55); Acc. MS(m/z), (Found: 
208.0733 (W+, 98%), C1 1 H1 2 04  requires: 208.0734, -0.5 ppm).
2-(3-Methoxypheny1)propanal (8 8 )
A mixture of the butenoic acid (87) (81.2 g, 0.49 mol) and 3 M 
hydrochloric acid (250 cm3) was placed in a two necked round 
bottomed flask (500 cm3) fitted with an inlet tube connected to a 
steam generator and a splash head fitted with a water condenser. The 
contents of the flask was then steam distilled until no further 
product was visible by tic in the distillate. The aqueous distillate was
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extracted with dichloromethane (3x1000 cm3) and the combined organic 
portions were washed with saturated aqueous sodium bicarbonate 
solution (250 cm3), dried (Na2 S04 ) and evaporated under reduced 
pressure to give a colourless oil (36.3 g). Distillation gave the title 
compound as a colourless oil (32.2 g, 40%). b.p. 122-123°C at 8  mmHg. 
IR(neat) vmax 2960, 2920, 2820, 2700, 1710 (CHO), 1590, 1580, 1480, 
1450, 1260, 1150, 1030, 900, 780 and 690 c m '1; *11 n.m.r. (CDC13) 6 H 
9.67 (1 H, d, J 1.3 Hz, CHO), 7.30 (1 H, t, J 7.9 Hz, 5’-H), 6.86-6.78 (2 
H, m, 4’- and 6 ’-H), 6.76 (1 H, t, J 2.0 Hz, 2’-H), 3.81 (3 H, s, 0CH3), 
3.60 (1 H, qd, J 7.0 and 1.3 Hz, 2-H) and 1.43 (3 H, d, J 7.0 Hz, 3-H); 
13C n.m.r. (CDC13) 8 C 200.8 (CHO), 160.1 (3’-C), 139.2 ( l ’-C), 130.0 
(Ar-CH), 120.5 (Ar-CH), 114.0 (Ar-CH), 112.6 (Ar-CH), 55.1 (0CH3), 52.9 
(2-C) and 14.4 (3-C); MS(E.I., low eV, m/z), 164 (tf+, 83%), 150 (18, 
W-CH2) and 135 (100, W-CHO); Acc. MS(m/z) (Found: 164.0831 {M+, 33%), 
Calc, for C1 0 H1 2 O2: 164.0837, -3.7 ppm).
2-(3-Methoxypheny1)propanal (8 8 )
Dry tetrahydrofuran (75 cm3) was added in one portion to a 
mixture of methoxymethyltriphenylphosphonium chloride (18.8 g, 54 
mmol) and potassium t-butoxide (8.0 g, 54 mmol) and the mixture 
stirred at room temperature for 45 min, under a nitrogen atmosphere. 
3’-Methoxyacetophenone (3.3 cm3, 3.7 g, 25 mmol) was added dropwise 
over a period of 15 min to the deep red solution of the ylid, and the 
solution was then stirred for a fu rther 1 h at room temperature. The 
solution was poured onto ice (200 g) and extracted with ether (3x50 
cm3). The combined extracts were washed with brine (20 cm3), dried 
(MgS04 ) and evaporated under reduced pressure to give a yellow oil. 
Purification of the intermediate enol ether by "suction flash” column
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chromatography on silica gel, eluting with ethyl acetate/60-80o C 
petroleum ether (using a gradient from 1:49 to 1:1) gave no separation 
due to the triphenylphosphine oxide by-product, which co-ran with 
the product. Perchloric acid (60-64%, 20 cm3) was added to a solution 
of the residue in ether (50 cm3), which was then stirred at room 
temperature for 16 h, under a nitrogen atmosphere. The solution was 
poured onto ice ( 1 0 0  g) and the mixture was extracted with ethyl 
acetate (3x50 cm3). The combined extracts were washed with a
saturated aqueous sodium bicarbonate solution (50 cm3), saturated 
brine (30 cm3), dried (MgS04) and evaporated under reduced
pressure to give a brown oil. Removal of the triphenylphosphine oxide 
by trituration with 60-80°C petroleum ether proved impossible. 
Purification by ’’suction flash" column chromatography on silica gel, 
eluting initially with 60-80° C petroleum ether and then a gradient 
mixture of ether/60-80oC petroleum ether (1:19 to 1:9 to 3:17) removed 
all traces of the triphenylphosphine oxide. Further purification by 
"suction flash" column chromatography on silica gel, eluting with 
ether/60-80° C petroleum ether (1:19), gave the title compound as a 
colourless oil (1.1 g, 27%). The spectral details were identical with 
those described previously for this compound (see p.6 6 ).
l - ( 3 - M e t h o x y p h e n y 1 ) - 1 - m e t h y I  o x i r a n e  (92)
Sodium hydride (60% dispersion in mineral oil, 1.51 g, 37.8 
mmol), which had been washed with dry 40-60°C petroleum ether (3x30 
cm3), and trimethyl sulphonium iodide (8 . 8  g, 40 mmol) were placed in 
a dry, three necked, round bottomed flask (250 cm3) fitted with an 
overhead s tirre r and a vacuum/nitrogen line. The flask was evacuated 
and then filled with nitrogen and this process was repeated twice.
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Dry dimethyl sulphoxide (40 cm3) was added slowly and the 
suspension stirred gently until hydrogen production had ceased. A 
solution of 3’-methoxyacetophenone (5.0 g, 33.3 mmol) in dry dimethyl 
sulphoxide (15 cm3) was added to the stirred suspension at room 
temperature, and the reaction mixture was then heated at 50°C for 2 
h. After cooling, the reaction mixture was poured onto ice (80 g) and 
extracted with ether (3x60 cm3). The combined organic extracts were 
washed with water (20 cm3), dried (Na2 S04), and evaporated under 
reduced pressure to give a yellow oil. Purification by "suction flash" 
column chromatography on silica gel, eluting with ethyl 
acetate/60-80o C petroleum ether (1:9), gave the title compound as a 
colourless oil (3.0 g, 52%). IR(neat) ^max 3040, 2960, 2920, 2830,
1600sh, 1580, 1480, 1450, 1420, 1290, 1220, 1045, 880, 830, 780 and 695 
cm-1; 1E n.m.r. (CDC13) 8 H 7.24(1 H, t, J 8.0 Hz, 5’-H), 6.95 (1 H, ddd, 
J 8.0, 2.6 and 1.0 Hz, 6 ’-H), 6.91 (1 H, m, 2’-H), 6.80 (1 H, ddd, J 8.0, 
2.6 and 1.0 Hz, 4’-H), 3.78 (3 H, s, 0CH3), 2.94 (1 H, d, /  5.5 Hz, 
E-2-H), 2.76 (1 H, dd, J 5.5 and 0.7 Hz,Z-2-H) and 1.69 (3 H, d, J 0.7 
Hz, 1-CH3); 13C n.m.r. (CDC13) 5C 159.6 (3’-C), 142.8 ( l ’-C), 129.3
(Ar-CH), 117.7 (Ar-CH), 112.9 (Ar-CH), 110.7 (Ar-CH), 56.8 (2-C), 56.6 
(1-C), 55.1 (0CH3) and 21.7 (1-CH3); MS(m/z) 164 (M+, 91%), 163 (94, 
M-H), 149 (41), 135 (48), 133 (8 6 ), 121 (50) and 91 (100); Analysis 
(Found: C, 72.7; H, 7.33, C1 0 H1 2 O2 requires: C, 73.1; H, 7.37%).
2-(3-Methoxypheny1)propanal (8 8 )
Boron trifluoride-etherate (1 cm3) was added dropwise to a
stirred solution of the oxirane (92) in dry ether, at 0°C. The reaction 
was stirred at room temperature for 15 min and then ether (100 cm3)
was added. The solution was washed with saturated aqueous sodium
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bicarbonate solution (2x30 cm3), dried (Na2 S04) and evaporated under 
reduced pressure to give a yellow oil (2.9 g). Purification by "flash" 
column chromatography on silica gel, eluting with ethyl 
acetate/60-80oC petroleum ether (1:9) gave the title compound as a 
colourless oil (1.9 g, 63.3%). The spectral details were identical with 
those described previously for this compound (see p.6 6 ).
4-(3-Methoxyphertyl)-4-methyl-2-cyclohexen-l-one (89)
A 40% methanolic solution of benzyltrimethylammonium 
hydroxide (26.6 cm3, 24.5 g, 59 mmol) was added over 1 h to a stirred 
solution of the aldehyde (8 8 ) (32.2 g, 196 mmol) and methyl vinyl
ketone (18.0 cm3, 15.1 g, 216 mmol) in t-butanol (150 cm3) at 0°C
under a nitrogen atmosphere. The reaction was stirred at room 
temperature for 2 h, then quenched on ice (300 g), and extracted with 
ether (3x300 cm3). The organic portions were combined, washed with 
saturated brine (50 cm3), dried (Na2 S04) and evaporated under
reduced pressure to give a pale yellow oil. Distillation gave the title 
compound as a colourless oil (30.0 g, 71%). b.p. 124-131 °C at 0.05
mmHg. IR(neat) vmax 2950, 2860sh, 2820, 1670 ( a, |3-unsaturated CO),
1590, 1570, 1480, 1450, 1420, 1280, 1250, 1220, 1200, 1050, 830, 780 and 
700 cm"1; ^  n.m.r. (CDC13) 6 H 7.27 (1 H, t, J 8.2 Hz, 5’-H), 6.93-6.87 
(3 H, m, 2-H, 2’-H and 6 ’-H), 6.79 (1 H, dd, J 8.2 and 2.5 Hz, 4’-H), 
6.11 (1 H, d, J 10.1 Hz, 3-H), 3.80 (3 H, s, 0CH3), 2.45-2.05 (4 H, m, 5- 
and 6 -H) and 1.54 (3 H, s, 4-CH3); 13C n.m.r. (CDC13) Sc 199.4 (CO), 
159.7 (3’-C), 156.9 (2-C), 146.9 ( l ’-C), 129.6, 128.5, 118.6, 112.9 and 
111.2 (4xAr-CH and 3-C), 55.2 (0CH3), 40.6 (4-C), 37.9 (6 -C), 34.6 (5-C) 
and 27.6 (4-CH3); MS(m/z) 216 (M+, 100%), 201 (29, W-CH3), 188 (35), 
174 (32), 173 (37) and 158 (50); Acc. MS(m/z) (Found: 216.1141 (M+,
-7 0 -
1 0 0 %), C1 4 H1 6 0 2 requires: 216.1148, -3.2 ppm).
4-(3-Methoxyphenyl)-4-methylcyclohexanone (76)
A solution of the cyclohexenone (89) (20.0 g, 92.4 mmol) in
glacial acetic acid ( 2 0 0  cm3) was hydrogenated in the presence of 1 0 % 
palladium on charcoal catalyst (1 . 0  g), at atmospheric pressure, until 
hydrogen uptake ceased. The reaction mixture was filtered through a 
bed of Celite to remove the catalyst, and the filter bed washed with 
ethyl acetate (4x100 cm3). Water (500 cm3) was added to the combined 
filtrates and the organic layer separated. The aqueous layer was
extracted with ethyl acetate (3x100 cm3). All the organic layers were 
combined, washed with water (100 cm3), saturated brine (50 cm3), 
dried (Na2 S04) and evaporated under reduced pressure to give a 
colourless oil. Crystallization from 60-80°C petroleum ether gave the 
title compound as colourless needles or plates (18.3 g, 91%). m.p. 
66.5-67.5° C. IR(neat) vmax 2950, 2860sh, 1710 (CO), 1590sh, 1570,
1480sh, 1450, 1420, 1280, 1220, 1050, 870, 780 and 700 cm’ 1; *H n.m.r. 
(CDC13) 6 h 7.31 (1 H, t, J 8.0 Hz, 5’-H), 7.03 (1 H, ddd, J 8.0, 2.1 and 
0.9 Hz, 6 ’-H), 6.99 (1 H, t, J 2.1 Hz, 2’-H), 6.79 (1 H, ddd, J 8.0, 2.1 
and 0.9 Hz, 4’-H), 3.83 (3 H, s, 0CH3), 2.55-1.85 ( 8  H, m, 4xCH2) and 
1.31 (3 H, 4 -CH3 ); 13C n.m.r. (CDC13) 8 C 211.5 (CO), 159.8 (3’-C), 147.6 
( l ’-C), 129.6 (Ar-CH), 117.9 (Ar-CH), 112.5 (Ar-CH), 110.2 (Ar-CH), 55.0 
(OCH3 ), 37.7 (4-C), 38.2 (2- and 6 -C), 37.0 (3- and 5-C) and 31.0 
(4 -CH3 ); MS(m/z) 218 (M+, 73%), 203 (8 ), 189 (12), 161 (73) and 148




hexylidene]-l-pyrrolidinamine (9 3 )
A mixture of (S )-l-amino-2-methoxymethylpyrrolidine (10 g, 77 
mmol) and the cyclohexanone (76) (16 g, 73 mmol) was heated at 60° C 
for 18 h, with stirring, under an argon atmosphere. The reaction 
mixture was allowed to cool and then dissolved in ether ( 2 0 0  cm3). 
This solution was washed with water (30 cm3), saturated brine (10 
cm3), dried (Na2 S04) and evaporated under reduced pressure to give 
a yellow oil. Distillation gave the title compound as a colourless oil 
(21.8 g, 90%). b.p.l76-178°C at 0.05 mmHg. [a ]D18°c +175.3° (c 0.5 in 
CHC13); IR(0.5% in CHBr3) vmax 2920, 2870sh, 2830, 1640w (CN), 1610, 
1580, 1490, 1460, 1430, 1240, 1050 and 780 c m '1; 1E n.m.r. (CDC13) 6 H 
(mixture of diastereomers -all signals doubled) 7.28 (1 H, 2xt, J 8.0 
Hz, 5”-H), 7.03-6.94 (2 H, m, 2”- and 6 ”-H), 6.79-6.73 (1 H, m, 4”-H), 
3.82 and 3.81 (3 H, 2xs, Ar-0CH3, 3.48-2.90 (5 H, m, 2-CH2, 2-H and
5-H), 3.37 and 2.20 (3 H, 2xs, CH2 0CH3), 2.58-1.59 (12 H, m, 6 xCH2), 
1.30 and 1.22 (3 H, 2xs, 4’-CH3); 13C n.m.r. (CDC13) 6 C 169.1 and 168.3 
(CN), 159.9 and 159.7 (3”-C), 150.1 and 148.5 (1”-C), 129.5 and 129.3 
(Ar-CH), 118.4 and 118.0 (Ar-CH), 112.9 and 112.5 (Ar-CH), 110.1 and
110.0 (Ar-CH), 75.5 and 75.3 (2-CH2), 66.0 and 65.9 (2-C), 59.2
(ArOCH3), 55.1 (CH2 OCH3), 55.1 and 54.7 (5-C), 38.3, 38.1, 37.8, 37.3,
36.9, 31.9 and 26.6 (4xCH2), 32.2 and 28.6 (4’-CH3), 25.8 and 25.7
(CH2), and 22.0 and 21.9 (CH2); MS(EI low eV, m/z) 330 (W + , 51%) and
285 (100); Analysis (Found: C, 72.3%; H, 9.15; N, 8.56, C2 0 H3 0 N2 O2
requires: C, 72.7; H, 9.17; N, 8.48%).
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(2 R, cis/trans,) - 4- (3 -m ethoxy pheny I ) -2 , 4-dimethylcyclo- 
hexanone (94)
n-Butyl lithium (1.6 M, 45.5 cm3) was added dropwise over a
period of 1 h to a stirred slurry of potassium t-butoxide (8.2 g, 73.1
mmol) and dry diisopropylamine (10.2 cm3, 7.4 g, 72.8 mmol), at -78°C 
and under an argon atmosphere. The suspension was then stirred at 
-78°C for 1 h. A solution of the chiral hydrazone (93) (21.8 g, 65.9
mmol) in dry ether (50 cm3) was added over a period of 30 min, at
-78° C. After stirring at -78°C for 10 h, the suspension was cooled to 
-110° C and a solution of methyl tosylate (14.77 g, 79.3 mmol) in dry 
ether (30 cm3) was added over a period of 30 min. Stirring was 
continued at -110°C for 2 h before the reaction was allowed to warm 
to room temperature overnight. The suspension was poured into a 
mixture of water (200 cm3) and ether (500 cm3), separated and the 
aqueous phase extracted with ether (3x200 cm3). The combined organic 
layers were washed with saturated brine ( 1 0 0  cm3), dried (Na2 S04) 
and evaporated under reduced pressure to give a pale yellow oil. This 
residue was dissolved in iodomethane (25 cm3) and heated at 40°C in 
a sealed tube for 16 h. After cooling, the solution was evaporated 
under reduced pressure to give a brown oil. The brown oil was 
stirred vigorously with a mixture of n-pentane (400 cm3) and 2.5 M 
hydrochloric acid (250 cm3) for 15 min. The n-pentane was then 
separated off and replaced with a fresh portion of n-pentane (400 
cm3), and the mixture stirred vigorously for a further 15 min. This 
process was repeated twice more and the combined n-pentane 
fractions were dried (Na2 S04) and evaporated under reduced 
pressure to give a colourless oil. Purification by "suction flash" 
column chromatography on silica gel, eluting with ethyl
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acetate/60-80°C petroleum ether (3:47) gave the tra n s - title  compound 
(78) (5.74 g, 37%), the c is - title  compound (79) (1.91 g, 13%) and a
mixture of the two, (78) and (79), (1.68 g, 11%) as colourless oils. 
Trans- (78): [a]Dl 8°c +18.1° (c 1.3 in CHC13); IR(neat) vmax 2940, 
2900sh, 2860, 1700 (CO), 1590, 1570, 1480sh, 1450, 1420, 1280, 1230,
1040, 870, 780 and 690 c m '1; *11 n.m.r. (CDC13) 8 H 7.33 (1 H, t, J 8.0 
Hz, 5’-H), 7.07 (1 H, ddd, J 8.0, 2.2 and 0.7 Hz, 6 ’-H), 7.02 (1 H, t, J
2.2 Hz, 2’-H), 6.80 (1 H, ddd, J 8.0, 2.2 and 0.7 Hz, 4’-H), 3.83 (3 H, s, 
0CH3), 2.65-2.53 (2 H, m, 2-Hax and 6 -Hax), 2.41-2.27 (3 H, m, 6 -Heq , 
5-Heq and 3-Heq), 1.84 (1 H, td, J 13.4 and 5.3 Hz, 5-Hax), 1.60 (1 H,
t, J 13.4 Hz, 3-Hax), 1.21 (3 H, s, 4-CH3) and 1.01 (3 H, d, J 6 . 6  Hz,
2-CH3); 13C n.m.r. (CDC13) 8 C 212.8 (CO), 160.1 (3’-C), 147.2 ( l ’-C), 
129.8 (Ar-CH), 118.1 (Ar-CH), 112.9 (Ar-CH), 110.2 (Ar-CH), 55.1 (0CH3),
46.7 (CH2), 41.3 (2-C), 39.2 (4-C), 38.6 (CH2), 37.9 (CH2), 33.6 (4-CH3) 
and 14.3 (2-CH3); MS(m/z) 232 (W + , 36%) and 148 (100); Analysis
(Found: C, 77.4; H, 8.85, C1 5 H2 0 0 2 requires: C, 77.5; H, 8.69%);
Enantiomeric excess 76% (±2%, determined by XH n.m.r. in CDC13 using 
0.060g TFAE and O.OlOg sample, splitting observed in singlet at 1.2 
ppm). Cis- (79): [a ] 0 l 8°c +4.0° (c 0.3 in CHC13); IR(neat) vmax 2960, 
2920, 2870, 2830, 1710 (CO), 1600, 1580, 1480, 1450, 1420, 1290, 1260, 
1050, 780 and 700 cm*1; *H n.m.r. (CDC13) 6 H 7.26 (1 H, t, J 8.0 Hz,
5’-H), 7.00-6.97 (1 H, m, 6 ’-H), 6.94 (1 H, t, J 2.2 Hz, 2’-H), 6.76 (1 H,
dd, J 8.0 and 2.2 Hz, 4’-H), 3.81 (3 H, s, 0CH3), 2.75-2.59 (2 H, m,
2-Hax and 6 -Hax), 2.41 (1 H, ddd, /  14.6, 4.6 and 2.8 Hz, 6 -Heq), 
2.23-2.09 (3 H, m, 5-Hax, 5-Heq and 3-Heq), 1.80 (1 H, t, J 13.3 Hz,
3-Hax), 1.59 (3 H, s, 4-CH3) and 1.06 (3 H, d, J 6.4 Hz, 2-CH3); 13C 
n.m.r. (CDC13) Sc 212.8 (CO), 159.6 (3’-C), 151.4 ( l ’-C), 129.2 (Ar-CH),
117.4 (Ar-CH), 111.9 (Ar-CH), 110.4 (Ar-CH), 55.1 (0CH3), 47.4 (CH2),
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40.8 <2-C), 38.4 (CH2), 38.3 (4-C), 38.0 (CH2), 24.4 (4-CH3) and 14.5 
(2-CH3); MS(m/z) 232 (W*, 73%), 175 (21), 161 (38) and 148 (100);
Analysis (Found: C, 77.3; H, 8.79, C1 5 H2 0 0 2 requires: C, 77.5; H,
8.69%).
4-(3-Methoxyphenyl)-2,4-dimethylcyclohexanone (94) via an 
ozonolytic hydrazone cleakage
A solution of the dimethyl chiral hydrazone (77) (0.20 g, 0.58 
mmol) in dichloromethane (3 cm3) was cooled to -78°C, under a 
nitrogen atmosphere, and ozone (180 V, 7.5 psi 0 3) was bubbled
through for 3 h. After the solution had turned a blue/green colour, 
nitrogen was bubbled through the solution while it was allowed to 
warm to room temperature. The solution was then evaporated under 
reduced pressure to give a yellow oil. Purification by distillation 
using a Kugelruhr apparatus gave impure title compound as a yellow
oil (0.020 g, 15%). b.p. 120°C (Kugelruhr) at 0.05 mmHg. The spectral
details were identical with those described previously for these 
compounds (see p.73).
4-(3-Methoxypheny1)-2,4-dimethy1-2-cyc1 ohexen-1-one (98)
A 40% methanolic solution of benzyltrimethylammonium hydroxide 
(0.8 cm3, 1.9mmol) was added dropwise, over a period of 20 min, to a 
stirred solution of the aldehyde (8 8 ) (1 . 0  g, 6 . 1  mmol) and ethyl vinyl 
ketone (0.56 g, 6 .8 mmol) in t-butanol (5 cm3) at 0°C under a nitrogen 
atmosphere. The reaction was stirred at room temperature for 2.5 h, 
then quenched on ice (25 g) and extracted with ether (3x15 cm3). The 
organic portions were combined, washed with saturated brine ( 1 0  
cm3), dried (Na2 S04) and evaporated under reduced pressure to give
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a pale yellow oil. Purification by "flash” column chromatography on 
silica gel, eluting with ethyl acetate/n-hexane (1:9), gave the title 
compound as a pale yellow oil (1.13 g, 80%). IR(neat) v'max 2960, 
2920sh, 2860sh, 2840, 1670 (CO), 1600, 1580, 1480, 1440, 1420, 1360, 
1250, 1040, 880, 780 and 700 cm"1; *H n.m.r. (CDC13) 6 H 7.26 (1H, t, J
8.0 Hz, 5’-H), 6.91 (1 H, ddd, J 7.9, 2.0 and 0.9 Hz, 6 ’-H), 6.87 (1 H, t, 
J 2.0 Hz, 2’-H), 6.78 (1 H, ddd, J 8.0, 2.0 and 0.9 Hz, 4’-H), 6 . 6 8  (1 H, 
q, J 1.3 Hz, 3-H), 3.80 (3 H, s, OCH3), 2.40-2.00 (4 H, m, 5- and 6 -H), 
1.88 (3 H, d, J 1.3 Hz, 2-CH3) and 1.51 (3 H, s, 4-CH3); 1 3C n.m.r. 
(CDC13) 5c 199.4 (CO), 159.5 (3’-C), 151.8 (3-C), 147.5 ( l ’-C), 134.3 
(2-C), 129.2 (Ar-CH), 118.4 (Ar-CH), 112.9 (Ar-CH), 110.6 (Ar-CH), 54.9 
(0CH3), 40.7 (4-C), 37.8 (6 -C), 34.4 (5-C), 28.0 (4-CH3) and 15.8
(2-CH3); MS(m/z), 230 (W+, 100%), 215 (25), 202 (21), 199 (15), 187 (41) 
and 173 (73); Analysis (Found: C, 78.5; H, 7.83, C1 5 H1 8 0 2 requires: C, 
78.2; H, 7.88%).
4-(3-Methoxyphenyl)-2,4-dimethylcyclohexanone (94)
A solution of the dimethylcyclohexenone (98) (1.10 g, 4.78 mmol) 
in glacial acetic acid ( 1 0  cm3) was hydrogenated in the presence of a 
1 0 % palladium on charcoal catalyst (0 . 1 1  g) at atmospheric pressure 
until hydrogen uptake ceased. The reaction mixture was filtered 
through a bed of Celite to remove the catalyst. A mixture of n-hexane 
( 1 0 0  cm3) and water ( 1 0 0  cm3) was added to the filtrate and the 
organic layer separated. The aqueous layer was extracted with a 
mixture of n-hexane/ether (1:1, 3x60 cm3). All the organic portions 
were combined, washed with saturated aqueous sodium bicarbonate 
solution (40 cm3), saturated brine (10 cm3), dried (MgS04) and
evaporated under reduced pressure to give a pale yellow oil (0.37 g).
-7 6 -
The filter bed was washed with ethanol (2x30 cm3) and this filtrate 
was evaporated under reduced pressure to give a yellow oil. This 
residue was dissolved in ethyl acetate ( 2 0  cm3) and the solution 
washed with water (20 cm3). The aqueous layer was washed with ethyl 
acetate (2x20 cm3). The combined organic portions were washed with 
saturated aqueous sodium bicarbonate solution ( 1 0  cm3), dried 
(MgS04) and evaporated under reduced pressure to give a yellow oil 
(0.68 g). These two residues were combined and purified by "flash” 
column chromatography on silica gel, eluting with ethyl 
acetate/n-hexane (2:23) gave the tra n s - title  compound (78) as a 
colourless oil (0.21 g, 19%), the c is - title  compound (79) as a 
colourless oil (0.46 g, 41%) and a mixture of the ci s / 1 ran s-title  
compound as a colourless oil (0.10 g, 9%). The spectral details were 
identical with those described previously for these compounds (p.73).
( 2S, E/Z )-2-Methoxymethyl-N-[4-(3-methoxyphenyl)-4-methyl-
2-cyclohexen-l-ylideveJ-l-pyrrolidinamine (134)
A solution of the cyclohexenone (76) (1.58 g, 7.32 mmol) and 
(S )-l-amino-2 -methoxymethylpyrrolidine (1 . 0  g, 7.64 mmol) in toluene 
(20 cm3) was heated under reflux in a Dean-Stark apparatus, in an 
argon atmosphere, for 12 h. After cooling, the solution was washed 
with water (5 cm3), dried (Na2 S04) and evaporated under reduced 
pressure to give a brown oil. Distillation using a Kugelruhr apparatus 
gave the title compound as a yellow oil (2.33 g, 97%). b.p. 160° C 
(Kugelruhr) at 0.05 mmHg. IR(0.5% solution in CHBr3) ^max 2960, 2940, 
2870, 2830, 1600, 1580, 1485, 1460, 1430, 1260, 1050 and 780 cm-1; 1R 
n.m.r. (CDC13) 8 H (mixture of 4 stereomers/diastereomers) 7.28-7.21 (1 
H, m, 5”-H), 6.97-6.74 (3 H, m, 2”-, 4”- and 6 ”-H), 6.33-6.09 (2 H, m,
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2’- and 3’-H), 3.82, 3.81, 3.80 and 3.79 (3 H, 4xs, Ar-OCH3), 3.53-3.20 
(7 H, m, CH2 OCH3, 2-H and 5-H), 2.68-1.61 (9 H, m, 4xCH2 and 5-H), 
1.48, 1.47, 1.46 and 1.43 (3 H, 4xs, 4’-CH3); Analysis (Found: C, 73.3; H, 
8.57; N, 8.52, C2 0 H2 8 N2 0 2 requires: C, 73.1; H, 8.61; N, 8.53%).
(6R)-(+)-4-(3-Methoxyphenyl)-4,6-dimethyl-2-cyclohexen-l- 
one (103)
n-Butyl lithium (1.2 M, 0.56 cm3, 0.69 mmol) was added dropwise 
over a period of 1 h to a stirred slurry of potassium t-butoxide 
(0.077 g, 0.69 mmol) and dry diisopropylamine (0. 1 cm3, 0.07 g, 0.69 
mmol) in dry tetrahydrofuran (5 cm3), at -78°C and under an argon 
atmosphere. The suspension was then stirred at -78°C for 1 h. A 
solution of the chiral hydrazone (134) (0.21 g, 0.65 mmol) in dry
tetrahydrofuran (1 cm3) was added dropwise at -78°C. After stirring 
at -78°C for 5 h, the suspension was cooled to -110° C and a solution 
of methyl tosylate (0.14 g, 0.72 mmol) in dry tetrahydrofuran (1 cm3) 
over a period of 15 min. Stirring was continued at -110° C for 30 min 
before the reaction was allowed to warm to room temperature 
overnight. The suspension was poured into a mixture of water (5 cm3) 
and ether (15 cm3), separated, and the aqueous phase extracted with 
ether (3x5 cm3). The combined organic layers were washed with
saturated brine (5 cm3), dried (Na2 S04) and evaporated under
reduced pressure to give a pale yellow oil (0.19 g). This residue was 
dissolved in iodomethane (5 cm3) and heated at 40°C in a sealed tube 
for 16 h. After cooling, the solution was evaporated under reduced 
pressure to give a brown oil. The brown oil was stirred vigorously 
with a mixture of n-pentane (15 cm3) and 3 M hydrochloric acid (15 
cm3) for 15 min. The n-pentane was then separated off and replaced
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with a fresh portion of n-pentane (15 cm3), and the mixture stirred 
vigorously for a further 15 min. This process was repeated twice more 
and the combined n-pentane fractions were dried (Na2 S04), and 
evaporated under reduced pressure to give a brown oil (0.066 g). 
Purification by "flash” column chromatography on silica gel, eluting 
with ethyl acetate/60-80o C petroleum ether (1:9) gave the title 
compound as a pale yellow oil (0.021 g, 16%). [a]D18° c +34.8° (c 0.6 in 
CHC13); IR(neat) ^max 2960, 2930, 2870, 1680 (<x, P-unsaturated CO), 
1605, 1580, 1480, 1450, 1430, 1370, 1290, 1260, 1050, 815, 780 and 700 
cm- 1 ; 1H n.m.r. (CDC13) SH (3:2 mixture of diastereomers) 7.33-7.24 (1 
H, m, 5’-H), 6.98-6.76 (4 H, m, 2’-, 4’-, 6 ’- and 2-H), 6.14 and 6.05 (1 
H, 2xd, J 10.0 Hz, 3-H), 3.81 (3 H, s, 0CH3), 2.89-2.60 (0.6 H, m, 6 -H of 
one diastereomer), 2.34-1.86 (2.4 H, m, 5-H and 6 -H of other
diastereomer), 1.64 and 1.49 (3 H, 2xs, 4-CH3), 1.13 and 1.02 (3 H, 2xd, 
J 6 . 6  Hz, 6 -CH3 ); Analysis (Found: C, 78.1; H, 8.18, C1 5 H1 8 0 2
requires: C, 78.2; H, 7.89%).
(^R -trans, E)-( + )-4-(3-Methoxypheny1)-2,4-dimethy 1 cyc 1 0 - 
hexanone oxime (1 0 2 )
A mixture of the trans-dimethylcyclohexanone (78) (5.68 g, 24.4 
mmol), hydroxylamine hydrochloride (6.79 g, 97.7 mmol) and sodium 
acetate (8.02 g, 97.7mmol) in 80% methanol (50 cm3) was stirred at 
room temperature for 18 h. The reaction mixture was poured into 
water (100 cm3) and extracted with ethyl acetate (4x50 cm3). The 
combined organic layers were washed with saturated aqueous sodium 
bicarbonate solution (30 cm3), saturated brine (25 cm3), dried
(Na2 S04) and evaporated under reduced pressure to give a colourless 
solid. Recrystallization from ether/60-80oC petroleum ether gave the
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title compound as a colourless crystalline solid (5.13 g, 85%). m.p. 
94-95°C. [a]D 1 8  °c +3.5° (c 1.1 in CHC13); IR(nujol mull) vmax 3250br, 
1675w, 1610, 1580, 1480, 1290, 1240, 1050, 945, 870, 780, 700 and 675 
cm"1; 1E n.m.r. (CDC13) 6 H 9.80 (1 H, br s, OH), 7.29 (1 H, t, J 8.0 Hz, 
5’-H), 7.00 (1 H, d, J 8.0 Hz, 6 ’-H), 6.96 (1 H, d, J 2.2 Hz, 2’-H), 6.75
(1 H, dd, J 8.0 and 2.2 Hz, 4’-H), 3.81 (3 H, s, 0CH3), 3.27 (1 H, dt, J
14.1 and 2.8 Hz, 6 -Heq), 2.50-2.38 (2 H, m, 3-Heq and 5-Heq), 2.38-2.20 
(1 H, m, 2-Hax), 1.82-1.49 (2 H, m, 5-Hax and 6 -Hax), 1.43 (1 H, t, J
13.3 Hz, 3-Hax), 1.15 (3 H, s, 4-CH3) and 1.09 (3 H, d, J 6.4 Hz, 
2-CH3); 13C n.m.r. (CDC13) 8 C 162.5 (CN), 159.9 (3’-C), 147.8 ( l ’-C),
129.6 (Ar-CH), 118.4 (Ar-CH), 113.0 (Ar-CH), 110.0 (Ar-CH), 55.1 (0CH3),
47.0 (CH2), 39.0 (4-C), 36.4 (CH2), 34.1 (4-CH3), 33.5 (2-CH3), 21.3 
(CH2) and 16.3 (2-CH3); MS(m/z) 247 (W + , 52%), 230 (25, M-OH), 149
(56) and 148 (28); Analysis (Found: C, 72.4; H, 8.54; N, 5.81,
C i5 H2 iN02 requires: C, 72.8; H, 8.57; N, 5.66%); Enantiomeric excess 
76% (±2%, determined by 1H n.m.r. in CDC13 using 0.035g TFAE and 
O.OlOg sample, splitting observed in singlet at 1.0 ppm).
( 2 R- cis, E)- (+ ) -4 - ( 3-Methoxyphenyl ) -2 , 4-dimethyl cycl o-
hexanone oxime (101)
A mixture of the c i s-dimethylcyclohexanone (79) (1.40 g, 6.0
mmol), hydroxylamine hydrochloride (1.47 g, 21.2 mmol) and sodium 
acetate (2.48 g, 30.2mmol) in 80% methanol (25 cm3) was stirred at 
room temperature for 18 h. The reaction mixture was poured into 
water (25 cm3) and extracted with ethyl acetate (4x30 cm3). The 
combined organic layers were washed with saturated aqueous sodium 
bicarbonate solution (15 cm3), saturated brine (15 cm3), dried
(Na2 S04) and evaporated under reduced pressure to give a colourless
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solid. Recrystallization from ether/60-80° C petroleum ether gave the 
title compound as a colourless crystalline solid (1.25 g, 84%). m.p. 
105-106°C. [a ] D 1 8  °c +48.4° (c 1.0 in CHC13); IR(nujol mull) vmax 
3200br, 1670w, 1600, 1590sh, 1470, 1270, 1240, 1180, 1040, 940, 890, 780 
and 700 c m '1; XH n.m.r. (CDC13) 6 H 9.10 (1 H, br s, OH), 7.25 (l H, t, 
J 8.0 Hz, 5’-H), 6.97 (1 H, m, 6 ’-H), 6.92 (1 H, t, J 2.2 Hz, 2’-H), 6.74 
(1 H, dd, J 8.0 and 2.2 Hz, 4’-H), 3.81 (3 H, s, 0CH3), 3.39 (1 H, m, 
6 -Heq), 2.68-2.58 (1 H, m, 2-Hax ), 2.10-1.75 (4 H, m, 3-Heq, 5-Hax ,
5-Heq and 6 -Hax ), 1.64 (1 H, t, J 13.0 Hz, 3-Hax), 1.44 (3 H, s, 4-CH3) 
and 1.14 (3 H, d, J 6.5 Hz, 2-CH3); 13C n.m.r. (CDC13) 6 C 162.3 (CN),
159.5 (3’-C), 152.3 ( l ’-C), 129.1 (Ar-CH), 117.5 (Ar-CH), 111.8 (Ar-CH),
110.4 (Ar-CH), 55.1 (0CH3), 47.4 (CH2), 37.4 (4-C), 36.7 (CH2), 33.1 
(4-CH3), 24.4 (2-CH3), 20.8 (CH2) and 16.5 (2-CH3); MS(m/z) 247 (M+, 
100), 230 (28, M-OH), 205 (20), 148 (33) and 121 (31); Analysis (Found: 
C, 72.7; H, 8.62; N, 5.61, C1 5 H2 1 N02 requires: C, 72.8; H, 8.57; N,
5.66%); Enantiomeric excess 60% (±4%, determined by *H n.m.r. in
CDC13 using 0.050g TFAE and O.OlOg sample, splitting observed in
singlet at 1.4 ppm).
Crystal Data.-C1 5 H2 1 N02, M = 247.37. Triclinic, a = 6.437 (2), b - 
10.830 (2 ), c = 11.366 (2 ) A,  a = 113.47 (2 ), 0  = 98.99 (2 ), r  = 101.65
(2 ), V - 686.75 A3 (by least squares refinement on diffractometer
angles for 1 2  automatically centred reflections, X = 0.71069 A), space 
group PI, Z = 2, Dy = 1.19 g cm-3 . Colourless rods. Crystal
dimensions: 0.3 x 0.3 x 0.3 mm, n(Mo-Ka ) = 0.44 cm- 1 .
Data Col lect ion and Processing.62- Hilger and Watts Y290
4-circle diffractometer, graphite monochromated Mo-Ka radiation; 1837 
reflections were measured (2 £ 0 < 22°), 1471 unique and 1151
observed with I > 3 o(I). No crystal decay was detected during data
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co llec tio n .
Structure Analysis and Re f inement .-Direct methods6 3  were 
successful in locating all non-hydrogen atoms. The structure was 
refined using SHELX76.64 The weighting scheme w - 8.1764 [o 2 (F0) + 
0.08 Fc 2], with a(Fc ) from counting statistics6 5  * 6 6 * 6 7  gave
satisfactory agreement analyses. Final R and values are 0.071 and 
0.074. Sources of scattering factor data are given in refs. 65-67.
( 5S- tra n s j-(-)-Hexahydro-5-(3-methoxypheny1)-5,7-d imethy1 -
2-azepinone (109)
Phosphorus oxychloride (15 cm3) was added dropwise to a 
stirred solution of the trans- oxime (102) (7.41 g, 30mmol) in dry
pyridine (35 cm3) at 0°C, under a nitrogen atmosphere. After stirring 
at 0°C for 5 h, the solution was carefully poured onto ice (250 g) and 
left for 1 h. Concentrated hydrochloric acid (37 cm3) was added 
slowly and the resulting mixture extracted with ethyl acetate (4x100 
cm3). The combined organic layers were washed with saturated 
aqueous sodium bicarbonate solution (100 cm3), saturated brine (50 
cm3), dried (Na2 S04) and evaporated under reduced pressure to give 
a yellow oil. Crystallization from n-pentane gave the title compound as 
a white crystalline solid (5.25 g, 71%). The mother liquor was 
evaporated under reduced pressure and purified by "suction flash" 
column chromatography on silica gel, eluting with ethyl 
acetate/60-80o C petroleum ether (4:1) to give the title compound as a 
colourless crystalline solid (0.80 g, 11%). m.p. 133-134°C. [«]D18°C 
-29.6° (c 1.2 in CHC13); IR(nujol mull) vmax 3200 (NH), 3080 (NH), 1670 
(CO), 1640sh, 1610, 1580, 1295, 1250, 1230, 1180, 1050, 880, 810, 780 and 
700 cm-1; 1E n.m.r. (CDC13) SH 7.33 (1 H, t, J 8.0 Hz, 5’-H), 6.85 (1 H,
-8 2 -
d, J 8.0 Hz, 6 ’-H), 6.83-6.75 (2 H, m, 2’- and 4’-H), 6.29 (1 H, br s, 
NH), 3.82 (3 H, s, OCH3, 3.56-3.40 (1 H, m, 7-H), 2.54-2.24 (4 H, m, 3-H, 
Ix4-H and Ix6 -H), 1.82-1.66 (1 H, m, Ix4-H), 1.59 (1 H, dd, J 14.8 and
9.5 Hz, Ix6 -H), 1.24 (3 H, d, J 6 . 8  Hz, 7-CH3) and 1.14 (3 H, s, 5-CH3); 
13C n.m.r. (CDC13) Sc 177.3 (CO), 159.9 (3’-C), 147.4 ( l ’-C), 129.7 
(Ar-CH), 118.5 (Ar-CH), 113.3 (Ar-CH), 110.1 (Ar-CH), 55.1 (OCH3), 48.3 
(CH2), 45.0 (7-C), 41.7 (5-C), 35.3 (CH3), 33.5 (CH2), 32.7 (CH2) and
22.3 (CH3); MS(m/z) 247 (tf+, 36%), 191 (16) 148 (30) and 99 (100); 
Analysis (Found: C, 72.9; H, 8 .6 6 ; N, 5.58, C1 5 H2 1 N02 requires: C, 72.8; 
H, 8.57; N, 5.66%); Enantiomeric excess 80% (±4%, determined by 1H 
n.m.r. in CDC13 using 0.030g TFAE and O.OlOg sample, splitting 
observed in singlet at 1 . 1  ppm).
(5 8 -c is^ -(-)-Hexahydro-5-(3-methoxyphenyl)-5, 7-dimethy1-2- 
azepinorre (1 1 0 )
Phosphorus oxychloride (3.4 cm3) was added dropwise to a 
stirred solution of the cis-oxime (101) (1.14 g, 4.6mmol) in dry
pyridine (7.5 cm3) at 0°C, under a nitrogen atmosphere. After stirring 
at 0°C for 5 h, the solution was carefully poured onto ice (50 g) and 
left for 1 h. Concentrated hydrochloric acid ( 8  cm3) was added slowly 
and the resulting mixture extracted with ethyl acetate (4x30 cm3). The 
combined organic layers were washed with saturated aqueous sodium 
bicarbonate solution ( 1 0  cm3), saturated brine ( 1 0  cm3), dried
(Na2 S04) and evaporated under reduced pressure to give a yellow oil. 
Crystallization from n-pentane gave the title compound as a colourless 
crystalline solid (8.83 g, 73%). m.p. 113-114°C. [a]D18° c -1.1° (c 1.2 in 
CHC13); IR(nujol mull) vmax 3200 (NH), 3080 (NH), 1640 (CO), 1600, 
1570, 1430, 1300, 1245, 1150, 860, 810, 780 and 700 cm"1; 1E n.m.r.
-8 3 -
(CDC13) 8 h 7 -2 5  d  H’ t, J 8.0 Hz, 5’-H), 6.97 (1 H, d, J 7.9 Hz, 6 ’-H), 
6.92 (1 H, t, J 2.0 Hz, 2’-H), 6.75 (1 H, dd, J 8.0 and 2.0 Hz, 4’-H),
6.55 (1 H, br s, NH), 3.80 (4 H, s, 7-H and OCH3), 2.75 (1 H, t, J 13.6
Hz, 3-H), 2.38 (1 H, dd, J 13.6 and 7.7 Hz, 3-H), 2.06 (1 H, t, J 13.6
Hz, 4-H), 1.87 (1 H, dd, J 14.5 and 10.2 Hz, 6 -H), 1.81 (1 H, dd, J 13.6
and 7.7 Hz, 4-H), 1.69 (1 H, d, J 14.5 Hz, 6 -H), 1.43 (3 H, s, 5-CH3)
and 1.25 (3 H, d, J 6 . 6  Hz, 7-CH3); 13C n.m.r. (CDC13) 6 C 177.2 (CO),
159.5 (3’-C), 152.0 ( l ’-C), 129.1 (Ar-CH), 117.5 (Ar-CH), 112.0 (Ar-CH),
110.5 (Ar-CH), 55.1 (OCH3), 49.7 (CH2), 44.2 (7-C), 39.6 (5-C), 34.7 
(CH2), 32.1 (CH2), 23.8 (CH3) and 22.7 (CH3); MS(m/z) 247 (W+, 79%), 
204 (30, W-CONH) and 189 (24); Analysis (Found: C, 73.0; H, 8 .6 6 ; N, 
5.68, C1 5 H2 1 N02 requires: C, 72.8; H, 8.57; N, 5.66%).
(5S- trans^- (-)-Hexahydro-5-(3-methoxyphenyl)-l,5t7-tri- 
me t h y 1-2-a z epinon e (80)
Dry tetrahydrofuran (50 cm3) was added to a mixture of the 
t r arts -caprolactam (109) (6.05 g, 24.5 mmol) and sodium hydride (97% 
oil dispersion, 1.21 g, 48.9 mmol), and the suspension was stirred at 
room temperature for 24 h, under a nitrogen atmosphere. Iodomethane 
(7.6 cm3, 17.4 g, 122 mmol) was added dropwise and the suspension 
was stirred at room temperature for a further 48 h. After quenching 
on ice (100 g), the mixture was extracted with ethyl acetate (4x50 
cm3), the organic layers combined, washed with saturated brine (30 
cm3), dried (Na2 S04) and evaporated under reduced pressure to give 
the pure title compound as a pale yellow oil (6.35 g, 99%). [<x]D18° c 
-1.8° (c 4.3 in CHC13); IR(neat) vmax 2960, 2880sh, 2840, 1640 (CO), 
1600, 1570, 1490, 1450, 1420, 1390, 1290, 1250, 1050, 870, 780 and 700 
cm"1; iH n.m.r. (CDC13) 5H 7.31 (1 H, t, J 8.0 Hz, 5’-H), 6.90 (1 H,
-8 4 -
ddd, J 8.0, 2.0 and 0.8 Hz, 6 ’-H), 6.84 (1 H, t, J 2.0 Hz, 2’-H), 6.78 (1
H, ddd, J 8.0, 2.0 and 0.8 Hz, 4’-H), 3.82 (3 H, s, OCH3), 3.67 (1 H, p,
J 8.0 Hz, 7-H), 2.86 (3 H, s, NCH3), 2.62 (1 H, t, J 12.8 Hz, 3-H),
2.56-2.37 (2 H, m, 3- and 4-H), 2.21 (1 H, dd, J 14.8 and 1.8 Hz, 6 -H),
I.70-1.56 (2 H, m, 6 - and 4-H), 1.30 (3 H, d, J 8.0 Hz, 7-CH3) and 1.12
(3 H, s, 5-CH3); i3 C n.m.r. (CDC13) Sc 175.6 (CO), 159.9 (3’-C), 147.5 
( l ’-C), 129.7 (Ar-CH), 118.5 (Ar-CH), 113.1 (Ar-CH), 110.2 (Ar-CH), 55.0 
(OCH3), 49.8 (7-C), 45.9 (CH2), 41.5 (5-C), 34.6 (CH3), 34.3 (CH2), 33.0 
(CH2), 27.3 (CH3) and 20.5 (CH3); MS(m/z) 261 (W*, 33%), 246 (2,
M-CH3), 204 (5, W-CONCH3) and 113 (100); Acc. MS(m/z) (Found:
261.1737 (M+, 100%), C1 6 H2 3 N02 requires: 261.1727, +3.8 ppm).
( cis )-Hexahydro-5-(3-methoxyphenyl)-1,5,7-trimethyl-2- 
azepinone (116)
Dry tetrahydrofuran (20 cm3) was added to a mixture of the 
c i s -caprolactam (110) (0.81 g, 3.3 mmol) and sodium hydride (97% oil 
dispersion, 0 . 2 0  g, 8 . 1  mmol), and the suspension was stirred at room 
temperature for 1 h, under a nitrogen atmosphere. Iodomethane (1.25 
cm3, 2.85 g, 20 mmol) was added dropwise and the suspension was
stirred at room temperature for a further 24 h. After quenching on
ice (20 g), the mixture was extracted with dichloromethane (4x10 cm3), 
the organic layers combined, washed with saturated brine ( 1 0  cm3), 
dried (Na2 S04) and evaporated under reduced pressure to give the 
pure title compound as a pale yellow oil (0.82 g, 96%). IR(neat) v,max 
2960, 2930, 2840, 1625 (CO), 1600sh, 1580, 1450, 1420, 1250, 1100, 1050, 
875, 780, 730 and 700 cm"1; 1E n.m.r. (CDC13) 8 H 7.25 (1 H, t, /  8.0 
Hz, 5’-H), 6.94 (1 H, ddd, J 8.0, 2.0 and 0.7 Hz, 6 ’-H), 6.89 (1 H, t, /
2.0 Hz', 2’-H), 6.75 (1 H, ddd, J 8.0, 2.0 and 0.7 Hz, 4’-H), 4.10 (1 H, p,
-8 5 -
J 7.4 Hz, 7-H), 3.81 (3 H, s, OCH3), 2.96-2.84 (1 H, m, 3-H), 2.90 (3 H, 
s, NCH3), 2.52 (1 H, ddd, J 14.5, 7.5 and 1.7 Hz, 3-H), 2.07-1.78 (3 H, 
m, 6 - and 2x4-H), 1.57 (1 H, d, J 14.3 Hz, 6 -H), 1.40 (3 H, s, 5-CH3) 
and 1.28 (3 H, d, J 7.4 Hz, 7-CH3); 13C n.m.r. (CDC13) Sc 175.2 (CO),
159.3 (3’-C), 151.6 ( l ’-C), 129.0 (Ar-CH), 117.4 (Ar-CH), 111.8 (Ar-CH),
110.1 (Ar-CH), 54.9 (0CH3), 49.0 (7-C), 46.5 (CH2), 39.1 (5-C), 34.9 
(CH2), 32.4 (CH2), 27.5 (CH3), 24.9 (CH3) and 20.5 (CH3); MS(m/z) 261 
{M+, 46%), 246 (7, W-CH3), 204 (24, M-C0NCH3) and 189 (26); Acc. 
MS(m/z) (Found: 261.1734 (W+, 100%), C1 6 H2 3 N02 requires: 261.1727,
+2.7 ppm).
( cis )-Benzyl hex ahydro-5-(3-methoxyphenyl)-5y7-dlmethyl-2- 
azepinone-1-carboxylate (113)
A solution of the c i s-caprolactam (110) (0.05 g, 0.2 mmol) in 
dry tetrahydrofuran (3 cm3) was added to sodium hydride (60% oil 
dispersion, 0.016 g, 0.4 mmol) and the resulting suspension was 
stirred at room temperature for 1 h, under a nitrogen atmosphere. 
Benzyl chloroformate (0.14 cm3, 0.17 g, 1.0 mmol) was added dropwise 
and the suspension was heated under reflux for 8  h. After cooling, 
the suspension was poured onto ice (5 g) and extracted with 
dichloromethane (4x3 cm3). The combined organic layers were washed 
with saturated brine (3 cm3), dried (Na2 S04 ) and evaporated under 
reduced pressure to give a yellow oil. Purification by "flash" column 
chromatography on silica gel, eluting with a gradient of ethyl 
acetate/60-80oC petroleum ether (3:22 to 1:1 to 1:0), gave the title 
compound as a colourless oil (0.038 g, 49%) and the starting compound 
(110) as a colourless oil (0.010 g, 19%). IR(solution in CHC13) v/max 
2920, 2830sh, 1740sh (CO), 1700 (CO), 1600sh, 1580, 1450, 1380, 1250br,
- 86 -
1090, 1040 and 880 cm"1; *H n.m.r. (CDC13) SH 7.42-7.31 (5 H, m,
5xPhH), 7.26 (1 H, t, J 7.9 Hz, 5’-H), 6.92 (1 H, ddd, J 7.9, 2.1 and 0.8 
Hz, 6 ’-H), 6.87 (1 H, t, J 2.1 Hz, 2’-H), 6.75 (1 H, ddd, J 7.9, 2.1 and 
0.8 Hz, 4’-H), 5.25 (2 H, s, PhCH2), 4.40-4.32 (1 H, m, 7-H), 3.80 (3 H, 
s, OCH3), 2.72 (2 H, ABXY, JAB 16.6 Hz, JAX 9.0 Hz, JAY 2.2 Hz, JBX 
1.9 Hz and JBY 10.3 Hz, 3-H), 2.36 (1 H, dd, J 15.3 and 9.4 Hz, 6 -H), 
2.22 (1 H, ddd, J 15.0, 9.0 and 1.9 Hz, Ix4-H), 1.89 (1 H, ddd, J 15.0,
10.3 and 2.2 Hz, Ix4-H), 1.82 (1 H, dd, J 15.3 and 2.0 Hz, 6 -H), 1.33 (3 
H, s, 5-CH3) and 1.21 (3 H, d, 7-CH3); MS(m/z) 381 (M+, 20%), 247 (11), 
198 (23), 167 (28) and 91 (100).
( cis,) -Hex a hydro -5 -  (3-methoxyphenyl)-5,7-dimethyl-l-(phenyl- 
methy 1 )-2-azepinone (114)
A solution of the c i s-caprolactam (110) (0.20 g, 0.8 mmol) in 
dry tetrahydrofuran (3 cm3) was added to sodium hydride (60% oil 
dispersion, 0.065 g, 1.6 mmol) and the resulting suspension was 
stirred at room temperature for 1 h, under a nitrogen atmosphere. 
Benzyl bromide (0.19 cm3, 0.28 g, 1.6 mmol) was added dropwise and 
the suspension was stirred at room temperature for 14 h. The 
suspension was poured onto ice (5 g) and extracted with 
dichloromethane (4x3 cm3). The combined organic layers were washed 
with saturated brine (3 cm3), dried (Na2 S04) and evaporated under 
reduced pressure to give a yellow oil. Purification by ’’flash” column 
chromatography on silica gel, eluting with ethyl acetate/60-80o C 
petroleum ether (1:1), gave the title compound as a colourless oil (0.14 
g, 51%) and the starting compound (110) as a colourless oil (0.05 g, 
25%). IR(neat) vmax 3070, 2960, 2920sh, 2820, 1625 (CO), 1600sh, 1580, 
1480sh, 1450, 1410, 1290, 1250, 1050, 940, 880, 750 and 700 cm"1; *H
-8 7 -
n.m.r. (CDC13) 6 H 7.34-7.19 ( 6  H, m, 5xPhH and 5’-H), 6.87 (1 H, ddd, J 
8.1, 2.2 and 0.8 Hz, 4’-H), 4.65 (2 H, ABq, J AB 15.6 Hz, PhCH2),
4.18-4.04 (1 H, m, 7-H), 3.78 (3 H, s, OCH3), 2.67 (2 H, ABX, J AB 13.5
Hz, JAX 10.3 Hz and JBX 8.1 Hz, 3-H), 2.15 (1 H, t, J 14.1 Hz, Ix6 -H), 
1.90 (2 H, ABX, JAB 14.5 Hz, JAx 10.3 Hz and JBX 8.1 Hz, 4-H), 1.49 (1 
H, d, J 14.1 Hz, Ix6 -H), 1.35 (3 H, s, 5-CH3) and 1.15 (3 H, d, J 7.1
Hz, 7-CH3); MS(m/z) 337 (M*, 67%), 322 (7, Af-CH3), 204 (10), 179 (20),
160 (23), 148 (23), 134 (25), 8 6  (100) and 84 (100); Acc. MS(m/z) 
(Found: 337.2075 (W+, 100%), C2 2 H2 7 NO2 requires: 337.2039, +10.0 ppm).
(5S,7R)-(+)-5-(3-Methoxyphenyl)-5-methyl-7-(N-methyltri- 
fluoroacetylamino)octan-2-one (81)
Methyl lithium (1.4 M, 14.2 cm3, 19.9 mmol) was added dropwise 
to a stirred solution of the methylcaprolactam (80) (5.2 g, 19.9 mmol) 
in dry tetrahydrofuran (100 cm3) at 0°C, under a nitrogen 
atmosphere, and the mixture was stirred  at room temperature for 2  h. 
After cooling to -23°C, trifluoroacetic anhydride (8.4 cm3, 12.5 g, 59.7 
mmol) was added dropwise and the solution was then allowed to warm 
to room temperature over the period of 1 h. The reaction was poured 
onto ice (200 g) and then extracted with ethyl acetate (4x75 cm3). The 
combined organic layers were washed with water (50 cm3), saturated 
brine (40 cm3), dried (Na2 S04) and evaporated under reduced
pressure to give a brown oil (12.5 g). Purification by ’’suction flash” 
column chromatography on silica gel, eluting with chloroform, gave the 
title compound as a pale yellow waxy solid (4.11 g, 55%) m.p. 79-80° C, 
and the starting compound (80) as a yellow oil (0.67 g, 13%). [a]D18° c 
+89.4° (c 1.3 in CHC13); IR(solution in CHC13) vmax 2960, 2850, 1710sh 
(CO), 1680 (CO), 1600, 1580, 1480sh, 1450, 1410. 1290, 1140, 1100,
- 88 -
1090sh, 1050sh and 870 cm-1 ; 1H n.m.r. (CDC13) SH (1:9 mixture of 
rotomers) 7.19 (1 H, t, J 7.9 Hz, 5’-H), 6.82-6.69 (3 H, m, 2’-, 4’- and
6 ’-H), 4.77 (1 H, m, 7-H), 3.78 (3 H, s, 0CH3), 2.65 (1 H, s, NCH3, minor
rotomer), 2.39 (1 H, q, J 1.7 Hz, NCH3, major rotomer), 2.32-1.52 ( 6  H,
m, 3-, 4- and 6 -H), 1.99 (3 H, s, 1-H), 1.52 (3 H, s, 5-CH3) and 1.08 (3
H, d, J 6 . 8  Hz, 8 -H); MS(m/z) 373 (tf*, 28%), 303 (5), 302 (7), 175 (6 6 ), 
154 (100) and 148 (89); Analysis (Found: C, 61.0; H, 7.05; N, 3.74, 
c 19H2 6F3N03 requires: C, 61.1; H, 7.03; N, 3.75%).
(5R*, 7R*)-5-(3-Methoxyphenyl)-5-methy1-7-(N-methylamino)- 
octan-2-one (117)
Methyl lithium (1.4 M, 2.25 cm3, 3.15 mmol) was added dropwise 
to a stirred solution of the methylcaprolactam (116) (0.82 g, 3.14 mmol) 
in dry tetrahydrofuran (20 cm3) at 0°C, under a nitrogen atmosphere, 
and the mixture was stirred at room temperature for 2 h. The solution 
was poured onto a mixture of ice (10 g) and 2 M hydrochloric acid (10 
cm3), and then extracted with dichloromethane (30 cm3). The organic 
layer was washed with 2 M hydrochloric acid (4x10 cm3) and the 
aqueous layers were combined and neutralized with sodium 
bicarbonate. The aqueous portion was extracted with dichloromethane 
(4x10 cm3), these combined organic layers washed with saturated
brine (5 cm3), dried (Na2 S04) and evaporated under reduced
pressure to give the title compound as a yellow oil (0.46 g, 5 3 %). 
IR(solution in CHC13) vmax 3200br (NH), 2900, 1700 (CO), 1570, 1420, 
1350 and 860 cm '1; *H n.m.r. (CDC13) 5H 7.23 (1 H, t, J 8.0 Hz, 5’-H), 
6.90-6.85 (1 H, m, 6 ’-H), 6.83 (1 H, t, J 2.0 Hz, 2’-H), 6.73 (1 H, dd, J
8.0 and 2.0 Hz, 4’-H), 3.81 (3 H, s, 0CH3), 2.68-2.56 (1 H, m, 7-H), 
2.34-1.97 (2 H, m, 3-H), 2.25 (3 H, s, NCH3), 2.03 (3 H, s, 1-H), 1.86 (2
-8 9 -
H, d, J 5.3 Hz, 6 -H), 1.85 -1.70 (1 H, m, 4-H), 1.32 (3 H, s, 5-CH3),
I.32-1.06 (2 H, m, NH and 4-H) and 0.70 (3 H, d, J 6.2 Hz, 8 -H); 13C
n.m.r. (CDC13) 6 C 208.9 (CO), 159.6 (3’-C), 148.1 ( l ’-C), 129.2 (Ar-CH),
119.0 (Ar-CH), 113.2 (Ar-CH), 110.4 (Ar-CH), 55.1 (OCH3), 51.9 (7-C),
51.6 (3-C), 40.1 (5-C), 38.9 (CH2), 36.8 (CH2), 33.8 and 30.0 (1-C and
NCH3), 23.6 and 21.7 (5-CH3 and 8 -C); MS(m/z) 277 (W+, 2%), 259 (11),
244 (7), 206 (7), 148 (21) and 111 (37); Acc. MS(m/z) (Found: 277.2034 
(M+, 4.5%), C1 7 H2 7 N02 requires: 277.2040, -2.9 ppm).
The organic layer from the acid washing was washed with saturated 
aqueous sodium bicarbonate solution (5 cm3), saturated brine (5 cm3), 
dried (Na2 S04) and evaporated under reduced pressure to give
impure starting compound (116) as a yellow oil (0.23 g, 28%).
(5R*,7R*)-5-(3-Methoxyphenyl)-5-methyl-7-[N-(phenylmethyl) 
amirtoJoctart-2-one (118)
Methyl lithium (1.4 M, 0.3 cm3, 0.41 mmol) was added dropwise 
to a stirred solution of the benzylcaprolactam (114) (0.13 g, 0.38 mmol) 
in dry tetrahydrofuran (3 cm3) at 0°C, under a nitrogen atmosphere, 
and the mixture was stirred at room temperature for 24 h. The 
reaction was poured onto ice (5 g) and then extracted with
dichloromethane (4x3 cm3). The combined organic layers were washed 
with saturated brine (3 cm3), dried (Na2 S04 ) and evaporated under 
reduced pressure to give a brown oil. Purification by ’’flash” column 
chromatography on silica gel, eluting with ethanol/ethyl acetate (1:49) 
gave the title compound as a pale yellow oil (0 . 0 1 1  g, 8 %), and the 
starting compound (114) as a colourless oil (0.095 g, 75%). IR(solution 
in CHC13) vmax 3830 (NH), 2900, 2820sh, 1700 (CO), 1640, 1590sh, 1575, 
1420, 1360, 1280, 1080, 1040 and 870 cm"1; 1R n.m.r. (CDC13) 6 H
-9 0 -
7.31-7.17 ( 6  H, m, 5xPhH and 5’-H), 6.87-6.69 (3 H, m, 2’-, 4’- and 
6 ’-H), 3.81 (3 H, s, OCH3), 3.61 (2 H, ABq, JAB 12.8 Hz, PhCH2),
2.63-2.56 (1 H, m, 7-H), 2.50-2.18 (1 H, br s, NH), 2.17-1.98 (1 H, m,
Ix3-H), 2.03 (3 H, s, 1-H), 1.90-1.68 (1 H, m, Ix3-H), 1.78 (2 H, d, J 5.3 
Hz, 6 -H), 1.39-1.15 (2 H, m, 4-H), 1.30 (3 H, s, 5-CH3) and 0.81 (3 H, d,
J 6.4 Hz, 8 -H); MS(m/z) 353 (« + , 2%), 348 (2, W-CH3), 335 (3, Af-H2 0),
320 (2), 310 (2, W-CH3 CO), 296 (3), 247 (6 ), 244 (4), 148 (34) and 134 
( 100 ) .
( 2R , 1 '  S ) -  (  + ) - 1 - ( 1 ,2-Dihydro-7-methoxy-l, 4-dimethy1 - 1 -  
naphthyl )-N-methyltrifluoroacetyl-2-propyl amine ( 120 )
A solution of hydrogen chloride in dry dioxane (5.3 M, 10 cm3) 
was added to a solution of the trifluoroacetamido ketone (81) (3.91 g,
10.5 mmol) in dry dioxane (40 cm3) and the resulting solution heated 
at 70 °C for 2 h, under a nitrogen atmosphere. After cooling, the 
solution was treated with methanol (500 cm3) and then evaporated
under reduced pressure until only 50 cm3 remained. This process was 
repeated twice more. The remainder of the solvent was removed under 
reduced pressure to give a yellow oil. Purification by "suction flash" 
column chromatography on silica gel, eluting with ethyl 
acetate/60-80oC petroleum ether (1:19), gave the starting compound 
(81) as a yellow oil (1 . 1 0  g, 28%) and the title compound as a 
colourless crystalline solid (2.35 g, 63%). m.p. 95-96°C. [a]D18° c
+43.9° (c 1.1 in CHC13); IR (nujol mull) vmax 1685 (CO), 1610, 1570,
1490, 1420, 1310, 1240, 1230, 1190, 1130, 1090, 1070, 850, 820, 760 and 
680 cm-1 ; -^H n.m.r. (CDC13) 6 H (1:4 mixture of rotomers) 7.15 (1 H, d, 
J 8 . 6  Hz, 5’-H), 6.79 (1H, d, J 2.6 Hz, 8 ’-H), 6.71 (1H, dd, J 8 . 6  and 2.6
Hz, 6 ’-H), 5.64-5.61 (1 H, m, 3’-H), 4.86-4.73 (1 H, m, 2-H, major
-9 1 -
rotomer), 4.11-4.05 (1 H, m, 2-H, minor rotomer), 3.79 (3 H, s, 0CH3), 
2.60 (3 H, s, NCH3, minor rotomer), 2.47 (3 H, q, J 1.7 Hz, NCH3, major 
rotomer), 2.31 -1.96 (3 H, m, 2xl-H and 2’-H), 2.04 (3 H, s, 4’-CH3), 
1.36 (3 H, s, l ’-CH3), 1.26 (1 H, dd, J 15.1 and 2.6 Hz, 2’-H), 1.12 (3 H, 
d, J 6.4 Hz, 3-H, minor rotomer) and 1.04 (3 H, d, J  7.0 Hz, 3-H, major 
rotomer); MS(m/z) 355 (Af+, 35%), 188 (100), 187 (94), 186 (71) and 172 
(47); Analysis (Found: C, 64.5; H, 6.91; N, 3.93, Cig H24F3N02 requires: 
C, 64.2; H, 6.82; N, 3.94%).
Crystal Data. -C1 gH2 4 F 3 N0 2. M = 355.44. Orthorhombic, a - 8.992
(3), b - 13.042 (3), c = 15.511 (5) A,  V = 1819.0 A 3 (by least squares 
refinement on diffractometer angles for 1 2  automatically centred 
reflections, \ = 0.71069 A ) ,  space group P2 1 2 1 2 1, Z = 4, Dx = 1.30 g 
cm"3. Colourless slabs. Crystal dimensions: 0.30 x 0.30 x 0.33 mm, 
M(Mo-Ka ) = 0.64 cm- 1 .
Data Collection and Processing. Hilger and Watts Y290
4-circle diffractometer, graphite monochromated Mo-Ka radiation; 1624 
reflections were measured (2 s €> s 24°), 895 were unique with I < 3 
< o(I). No crystal decay was detected during data collection. 
Structure Ana 1 ys i s and Refinement.- Direct methods6 3  were 
successful in locating all non-hydrogen atoms. The structure was 
refined using SHELX76.64 The weighting scheme w - 8.1764 [o 2 (FQ) +
0.08 F02], with o(F0) from counting statistics6 5  * 6 6 * 6 7 gave
satisfactory agreement analyses. Final R and Rw values were 0.0925. 
Sources of scattering factor data are given in refs. 65-67.
(2R *,1 ' R*)-l-(1,2-Dihydro-7-methoxy-l, 4-dimethy1 - 1- 
naphthy 1 )-N-methy 1 -2-propy lamine (119)
Concentrated hydrochloric acid (0.3 cm3) was added dropwise to
-9 2 -
a solution of the aminoketone (117) (0.23 g, 0.83 mmol) and the
solution was heated at 70°C for 6  h, under a nitrogen atmosphere. 
After cooling, water (20 cm3) was added and the solution was basified 
with 2 M aqueous sodium hydroxide solution. The mixture was 
extracted with dichloromethane (4x10 cm3) and the combined organic 
portions were washed with saturated brine (5 cm3), dried (Na2 S04) 
and evaporated under reduced pressure to give a yellow oil. 
Purification by "flash" column chromatography on silica gel, eluting 
with dichloromethane/ethanol/aqueous ammonia (90:8:1), gave the title 
compound as a colourless oil (0.13 g, 61%). IR(solution jn CHC13) 
vmax3300br w (NH), 2900, 2840sh, 1710w, 1600, 1570sh, 1480, 1450, 1370, 
1290 and 1050 cm-1; 1E n.m.r. (CDC13) SH 7.18 (1 H, d, J 8.5 Hz, 
5’-H), 6.87 (1 H, d, J 2.7 Hz, 8 ’-H), 6.71 (1 H, dd, J 8.5 and 2.7 Hz,
6 ’-H), 5.62 (1 H, m, 3’-H), 3.81 (3 H, s, 0CH3), 2.47 (1 H, m, 1-H), 2.29
(3 H, s, NCH3), 2.26-2.17 (2 H, m, 2’-H), 2.02 (3 H, d, J 1.1 Hz, 4’-CH3),
1.55 (2 H, ABX, JAB 14.2 Hz, JAXrBX 4.9 Hz, 1-H), 1.35 (3 H, s, 2-CH3), 
1.17 (1 H, br s, NH) and 0.74 (3 H, d, J 6.2 Hz, 3-H); 13C n.m.r.
(CDC13) 8 c 124.3, 121.3, 111.9 and 109.8 (3’-, 5’-, 6 ’- and 8 ’-C), 55.2
(0CH3), 52.1 (2-C), 47.4 (CH2), 36.8 (CH2), 33.9 (NCH3), 29.7 ( l ’-C), 26.9
(4’-CH3), 22.2 and 19.4 (3-C and l ’-CH3); MS(m/z) 259 (W + , 8 %), 213 
(5), 188 (48), 186 (40) and 173 (31); Acc. MS(m/z) (Found: 259.1933 (Af+, 
12%), C1 7 H2 5 N0 requires: 259.1934, -1.2 ppm).
(2 R* , 1 ' R*)-!-(1, 2-Di hydro-7-methoxy- 1 , 4-dimethy1 -1- 
naphthy 1 ) - N-me th y 1 - 2-propy 1 am irte (119)
A mixture of the aminoketone (117) (0.050 g, 0.18 mmol) and
polyphosphoric acid (0.3 g) were heated at 120°C for 5 min, under a 
nitrogen atmosphere. After cooling, cold 2 M aqueous sodium
- 93-
hydroxide solution (5 cm3) was added slowly and the mixture 
extracted with dichloromethane (4x3 cm3). The combined organic layers 
were washed with saturated brine (3 cm3), dried (Na2 S04) and
evaporated under reduced pressure to give a yellow oil (0.047 g). 
Purification by ’’flash” column chromatography on silica gel, eluting 
with dichloromethane/ethanol/aqueous ammonia (2 0 0 :8 :1 ), gave the title 
compound as a colourless oil (0.005 g, 10%) and the starting compound 
(119) as a pale yellow oil (0.020 g, 40%). The spectral details were 
identical with those described previously for this compound (p.92).
(2R ,1'S)-( + )-!-(1,2-Dihydro-7-methoxy-l, 4-6imethy1 - 1- 
naphthy 1 j-N-me thy 1-2 -propyl amine (132)
A mixture of the trifluoroacetamido dihydronaphthalene (120) 
(0.50 g, 1.41 mmol) and anhydrous potassium bicarbonate (1.0 g, 7.24 
mmol) in 80% methanol (5 cm3) was treated with ultrasound in an 
ultrasonic bath for 18 h, under a nitrogen atmosphere. The resulting 
solution was poured into water ( 1 0  cm3) and extracted with ethyl 
acetate (4x10 cm3). The combined organic layers were washed with 
saturated brine (5 cm3), dried (Na2 S04) and evaporated under
reduced pressure to give the pure title compound as a pale yellow oil 
(0.36 g, 99%). [a]D 1 8  ° c +40.8° (c 1.4 in CH2 C12); IR(neat) vmax 3360w 
(NH), 3040sh, 2970, 2940sh, 2840, 2790, 1685w, 1610, 1570, 1490, 1460, 
1420, 1380, 1310, 1230, 1070, 1040 and 840 cm"1; *H n.m.r. (CDC13) SH 
7.19 (1 H, d, J 8.4 Hz, 5 '-H), 6.89 (1 H, d, J 2.6 Hz, 8 '-H), 6.73 (1 H, 
dd, J 8.4 and 2.6 Hz, 6 '-H), 5.65-5.58 (1 H, m, 3'-H), 3.82 (3 H, s, 
0CH3), 2.43 (1 H, pd, J 6.4 and 3.3 Hz, 2-H), 2.32-2.23 (1 H, m, 2’-H), 
2.12-2.02 (1 H, m, 2’-H), 2.03 (3 H, m, 4’-CH3), 1.99 (3 H, s, NCH3), 1.94 
(1 H, dd, J 14.4 and 6.4 Hz, 1-H), 1.33 (3 H, s, l ’-CH3), 1.25 (2 H, br s
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and dd, J 14.4 and 3.3 Hz, NH and 1-H) and 0.98 (3 H, d, J 6.4 Hz,
3-H).
T| ^ — cis/trans- [( 2 R* , 1 ' R* )-!-(1 t2-Dihydro-7-methoxy-l , 4- 
d imethy1-1-naphthy1/  - N -methyl-2-propylamin e]c h r om ium 
tricarbonyl (129) and (128)
Chromium hexacarbonyl (0.12 g, 0.55 mmol) and the amino 
dihydronaphthalene (119) (0.13 g, 0.50 mmol) were placed in a round 
bottomed flask (5 cm3) fitted with a water condenser and a 
nitrogen/vacuum system. After the system had been thoroughly 
flushed out with nitrogen, a degassed solution of di-n-butyl ether (3 
cm3) and tetrahydrofuran (0.3 cm3) was added v i a cannula and the 
mixture was heated under reflux for 30 h. (The solution had changed 
colour from orange to black in this time.) The solution was allowed to 
cool before being filtered through an alumina pad which had been 
previously flushed with nitrogen. A degassed solution of 
dichloromethane/ethanol/triethylamine (90:8:1) was used to wash the 
filter pad, and the combined filtrates were evaporated under reduced 
pressure to give an orange oil. Purification by "flash” column 
chromatography on silica gel (which had been flushed with nitrogen 
prior to use), eluting with a degassed solution of 
dichloromethane/ethanol/triethylamine (180:8:1) gave the title compound 
as an orange oil (0.048 g, 24%), which was sensitive to both air and 
light. 1H n.m.r. (CDC13) SH (2:1 mixture of two stereomers) 5.69-5.12 (4 
H, m, 3’-, 5’-, 6 ’- and 8 ’-H), 3.72 (3 H, s, 0CH3), 2.68-2.39 (2 H, m), 
2.36-2.20 (1 H, m), 2.28 major and 2.17 minor (3 H, 2xs, NCH3), 1.88 (3 
H, s, 4’-CH3), 1.68-1.09 (3 H, m), 1.47 major and 1.16 minor (3 H, 2xs, 
l ’-CH3) and 0.90 minor and 0.72 major (3 H, 2xd, J 6  Hz, 3-H).
- 95-
Tid-c is /tran s-f  (2R,l'S)-l-(l,2-Dihydro-7-methoxy-l,4- 
dimethyl-l-naphthyl)-N-methyltrifluoroacetyl-2-propyl- 
aminejchromium tricarbonyl (130) and (82)
Chromium hexacarbonyl (0.68 g, 3.09 mmol) and the trifluoro- 
acetamido dihydronaphthalene (1 2 0 ) (1 . 0 0  g, 2.81 mmol) were placed in 
a round bottomed flask (50 cm3) fitted with a water condenser and a 
nitrogen/vacuum system. After the system had been thoroughly 
flushed out with nitrogen, a degassed solution of di-n-butyl ether (18 
cm3) and tetrahydrofuran ( 2  cm3) was added via cannula and the 
mixture was heated under reflux for 40 h. (The solution had changed 
colour from orange to green in this time.) The solution was allowed to 
cool before being filtered through an alumina pad which had been 
previously flushed with nitrogen. A degassed solution of 60-80° C 
petroleum ether and then ethyl acetate was used to wash the filter 
pad, and the filtrate was evaporated under reduced pressure to give 
an orange oil. Purification by "flash” column chromatography on silica 
gel (which had been flushed with nitrogen prior to use), eluting with 
a gradient of degassed ethyl acetate/60-80°C petroleum ether (3:22 to 
3:17 to 1:4) gave the trans-title (82) compound as a yellow/orange 
microcrystalline solid (0.49 g, 36%) m.p. 95-96 °C, the c is - title  
compound (130) as an orange waxy solid (0.05 g, 4%) m.p. 105-106°C 
and the starting compound (1 2 0 ) as a pale yellow crystalline solid 
(0.58 g, 58%). Trans -complex: IR(nujol mull) vmax 1960, 1950, 1890 and 
1850 (Cr-CO), 1680 (amide CO), 1540, 1280, 1240, 1190, 1150, 1090, 1020 
and 670 cm"1; n.m.r. (CDC13) 8 H 5.66 (1 H, d, J 6  Hz, 3’-H), 5.58 (1 
H, d, J 7 Hz, 5’-H), 5.19-5.14 (2 H, m, 6 ’- and 8 ’-H), 4.82 (1 H, br p, J 
7 Hz, 2-H), 3.70 (3 H, s, 0CH3), 2.63 (4 H, m and s, NCH3 and Ix2’-H), 
2.2k (1 H, dd, J 14 and 9 Hz, lxl-H), 2.09 (1 H, dd, J 17 and 7 Hz,
- 96-
2.24 (1 H, dd, J 14 and 9 Hz, lxl-H), 2.09 (1 H, dd, J 17 and 7 Hz, 
Ix2’-H), 1.92 (3 H, s, 4’-CH3), 1.44 (3 H, s, l ’-CH3), 1.28 (1 H, d, J 14 
Hz, lxl-H) and 1.08 (3 H, d, J 7 Hz, 3-H); 13C n.m.r. (CDC13) 8 C 233.3 
(Cr-CO), 140.7 (4’-C), 128.2 (7’-C), 125.0 (3’-C), 117.7 and 97.2 (4’a- 
and 8 ’a-C), 90.0, 77.6 and 76.9 (5’-, 6 ’- and 8 ’-C), 55.3 (OCH3), 47.0 
(2-C), 41.1 and 37.4 (2’- and 1-C), 35.9 ( l ’-C), 32.4 (NCH3), 23.7, 20.0 
and 18.7 (3xCH3); MS(m/z, Cl) 492 (W+l, 18%), 491 (23, W + ), 407 (16, 
M-3xCO), 356 (100), 355 (48, W-Cr(CO)3), 188 (43), 187 (52) and 186 
(49); Analysis (Found: C, 53.9; H, 5.05; N, 2.84, C2 2 H2 4 CrF3 N05 
requires: C, 53.8; H, 4.93; N, 2.85%). Cis -complex: IR(nujol mull) vmax 
1970, 1940, 1890, 1860 and 1840sh (Cr-CO), 1690 (amide CO), 1540, 1380, 
1280, 1240, 1180, 1140, 1100, 1020, 750, 710 and 670 c m '1; !H n.m.r. 
(CDC13) 6 h 5.69-5.59 (2 H, m, 3’- and 5’-H), 5.17-5.04 (3 H, m, 2-, 6 ’- 
and 8 ’-H), 3.72 (3 H, s, 0CH3), 3.05 (3 H, s, NCH3), 2.59-2.02 (3 H, m, 
2x2’-H and lxl-H), 1.88 (3 H, s, 4’-CH3), 1.31 (3 H, d, J 7 Hz, 3-H) and 
1.17-1.02 (4 H, m and s, lxl-H and l ’-CH3); 13C n.m.r. (CDC13) 8 C 
233.5 (Cr-CO), 141.7 (4’-C), 127.3 (7’-C), 125.0 (3’-C), 118.6 and 97.3 
(4’a- and 8 ’a-C), 90.5, 77.2 and 75.0 (5’-, 6 ’- and 8 ’-C), 55.7 (0CH3), 
47.1 (2-C), 41.6 and 33.9 (2’- and 1-C), 35.4 ( l ’-C), 26.5, 20.4 and 18.8 
(3xCH3); MS(m/z) 407 (M-3xC0, 18%), 355 (41, M-Cr(C0)3), 213 (11), 201 
(13), 188 (85), 187 (100) and 186 (93); Acc. MS(m/z) (Found for 
fragment: 407.1180 (Af-3xC0, 22%), Cx 9 H2 4 CrF3 N02 requires: 407.1158, 
+5.4 ppm).
(1R, 2S,4R,6R)-(-)-1 , 2 , 3,4,5,6-Hexahydro-8-methoxy-lt3 ,4,6- 
tetramethyl-2t6-methar}o-3-benzazocine (83)
Degassed aqueous methanol (67%, 6  cm3) was added ria cannula 
to a mixture of T]6 -t ran s-trifluoroacetamidodihydronaphthalene
-9 7 -
chromium tricarbonyl complex (82) (0 . 1 0  g, 0 . 2  mmol) and anhydrous 
potassium carbonate (0.20 g, 1.4 mmol) under an argon atmosphere. 
The mixture was treated with ultrasound in an ultrasonic bath for 72 
h, during which time the potassium carbonate went into solution. At 
the end of this period three components were visible by t.l.c.: the 
starting material (82); the amino derivative of the starting material
(135), and the chromium tricarbonyl complex of the title compound 
(133). The solution was added to water (5 cm3) and extracted with 
ethyl acetate (4x5 cm3). The combined organic portions were washed 
with brine (3 cm3) and quickly dried (Na2 S04 ) and evaporated under 
reduced pressure to give an orange oil (0.08 g). This residue was 
then dissolved in (5 cm3) and placed in a sunlit position, in the 
presence of air, for 24 h. (After this time the orange solution had 
changed into a green suspension.) The suspension was evaporated 
under reduced pressure and the residue then purified by "flash" 
column chromatography on silica gel, eluting with 
dichloromethane/ethanol/aqueous ammonia (1 0 0 :8 :1 ) to give a mixture of 
the title compound and the aminodihydronaphthalene (132). Further 
purification by preparative t.l.c. on silica gel (1 mm, 60 GF254 Merck), 
using the same eluant as before, gave the the aminodihydro­
naphthalene (132) (0.030 g, 57%) and the pure title compound as a 
white waxy solid (0.009 g, 17% overall yield, 40% based on recovered 
aminodihydronaphthalene, 8 8 ). m.p. 66-67°C. [<x]018°c -59.3° (c 2.0 in 
CH2 C12); IR(solution in CHC13) vmax 2980, 2920sh, 2900sh, 2500w, 1600, 
1570, 1480, 1450, 1420sh, 1370, 1300, 1280, 1160, 1100, 1090, 1040, 1010, 
900 and 860 cm"1; *H n.m.r. (CDC13) 8 H 7.08 (1 H, d, J 8.4 Hz, 10-H), 
6.80 (1 H, d, J 2.7 Hz, 7-H), 6.73 (1 H, dd, J 8.4 and 2.7 Hz, 9-H), 3.79 
(3 H, s, 0CH3), 3.12 (1 H, q, /  7.1 Hz, 1-H), 2.88 (1 H, t, J 3.1 Hz,
- 98-
2-H), 2.42 (3 H, s, NCH3), 2.13-1.92 (2 H, m, 1x4- and lxll-H ), 1.69 (1 
H, ddd, J 12.6, 3.8 and 1.1 Hz, lxll-H), 1.35 (5 H, s and m, 6-CH3 and
5-H), 1.22 (3 H, J 7.1 Hz, 1-CH3) and 0.92 (3 H, d, J 6.2 Hz, 4-CH3); 
13C n.m.r. (CDC13) 8C 157.7 (8-C), 145.4 and 145.6 (6a- and lOa-C), 
128.9, 111.2 and 110.1 (7-, 9- and 10-C), 62.8 (CH), 55.1 (OCH3), 50.1 
(CH and CH2), 39.7 (NCH3), 36.0 (CH2), 33.8 (6-C), 29.6 (1-C), 28.0, 24.9 
and 20.6 (3xCH3); MS(m/z) 259 (tf+, 20%), 244 (100, tf-CH3), 187 (16) 
and 124 (31); Acc. MS(m/z) (Found: 259.1936 (M+, 26%), C17H25NO
requires: 259.1934, +0.8 ppm); Enantiomeric excess 86% (±2%,
determined by *H n.m.r. in CDC13 using 0.050g TFAE and 0.007g 
sample, splitting observed in doublet at 0.9 ppm).
Attempted synthesis of (2S*, 4S* ,6R*)- 1 , 2 %3 , 4 , 5 , 6 -hexahydro 
-8-methoxy-l,3,4,6-tetram ethyl-2,6-methano-3-benzazocine
(136)
The amino chromium complex (123) (0.043 g, 0.11 mmol) was
placed in a round bottomed flask (5 cm3), fitted with a
nitrogen/vacuum system, and the system was thoroughly flushed out 
with nitrogen. A degassed solution of dry ether (2 cm3) was added 
via cannula and the solution cooled to 0°C. A degassed solution of 
t-butyl lithium (1.87 M, 0.06 cm3, 0.11 mmol) was added, again via 
cannula, to the stirred solution at 0°C. After stirring at 0°C for 15 
min, the solution was cooled to -78° C and a degassed aqueous solution 
of ammonium chloride (1 cm3) was added via cannula. The solution 
was allowed to warm to room temperature over the period of 1 h. No 
higher running product was visible by t.l.c. After a normal work up 
procedure only starting material was recovered.
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Attempted synthesis of t i 5  - trans- [(1R, 2 S , 4R, 6R) -1 , 2 , 3 , 4 , 5 ,
6-hexahydro-8-methoxy-l,3t4,6-tetramethyl-l-methylthio- 
2 t6-methano-3-benzazocine]chromium tricarbonyl (137)
The trifluoroacetamido chromium complex (123) (0.20 g, 0.41
mmol) was placed in a round bottomed flask (10 cm3), fitted with a 
nitrogen/vacuum system, and the system was thoroughly flushed out 
with nitrogen. A degassed solution of dry ether (5 cm3) was added 
via cannula and the solution cooled to -78°C. A degassed solution of 
methyl lithium (1.4 M, 0.48 cm3, 0.66 mmol) was added, again via 
cannula, to the stirred solution at -78° C. After stirring at -78° C for 2 
h, a degassed solution of dimethyl disulphide (0.11 cm3, 0.12 g, 1.23 
mmol) in dry ether (1 cm3) was added via cannula, at -78°C. The 
solution was stirred at -78° C, under a nitrogen atmosphere, for 10 h 
and then allowed to warm to room temperature over the period of 1 h. 
Water (5 cm3) was added and the mixture was extracted with ethyl 
acetate (4x5 cm3). The combined organic layers were washed with
saturated brine (5 cm3), dried (Na2S04 ) and evaporated under
reduced pressure to give an orange oil. Purification by "flash" column 
chromatography on silica gel, eluting with a degassed solution of 
dichloromethane/ethanol/triethylamine (250:8:1), gave the starting 
compound (102) (0.080 g, 40%), the amino chromium complex (135)
(0.050 g, 31%) and the acetamido chromium complex (131) (0.015 g, 8%) 
as orange oils. The acetamido chromium complex (131) was dissolved in 
ether (3 cm3) and stood in a sunlit position in the presence of air, 
for 24 h, until the solution had changed colour from yellow to dark 
green. The solution was evaporated under reduced pressure and then 
purified by "flash" column chromatography on silica gel, eluting with 
dichloromethane/ethanol/aqueous ammonia (100:8:1), to give the
- 100-
acetamido dihydronaphthalene (138) as a colourless oil (0.007 g, 5%). 
[oc]d18° c +41.1° (c 1.1 in CH2C12); IR(solution in CHC13) vmax 2980, 
2820sh, 1650 (CO), 1600, 1570, 1490, 1420, 1310, 1240, 1080, 1040, 850, 
820 and 760 cm-1 ; 1H n.m.r. (CDC13) 6H (3:1 mixture of rotomers,
major rotomer) 7.14 (1 H, J 8.4 Hz, 5-H), 6.83 (1 H, d, J 2.6 Hz, 8-H),
6.70 (1 H, dd, J 8.4 and 2.6 Hz, 6-H), 5.67-5.58 (1 H, m, 3-H), 5.04-4.91
(1 H, m, l ’-H), 3.83 (3 H, s, 0CH3), 2.18 (3 H, s, NCH3), 2.32-2.07 (2 H, 
m, 2- and/or 2’-H), 2.04 (3 H, m, 4-CH3), 1.77 (3 H, s, C0CH3),
1.46-1.10 (2 H, m, 2- and/or 2’-H), 1.37 (3 H, s, 1-CH3) and 0.93 (3 H, 
d, /  7.2 Hz, l ’-CH3); MS(m/z) 301 (M+, 16%), 223 (11), 186 (72), 115
(100); Acc. MS(m/z) (Found: 301.2039 (Af+, 24%), C19H27N02 requires: 
301.2039).
Amino complex: IR(neat) vmax 3350br w (NH or H20), 2960, 2940, 2720 
(NH+), 2460 (NH+), 1950 and 1860 (Cr-CO), 1600, 1540, 1460, 1440sh, 
1380, 1280, 1230, 1060, 1020, 910, 840, 730 and 670 cm '1; *H n.m.r. 
(CDC13) 8h 5.62-5.56 (2 H, m, 3- and 5-H), 5.30-5.14 (2 H, m, 6- and 
8-H), 3.73 (3 H, s, 0CH3), 2.97-2.48 (2 H, m), 2.30 (3 H, s, NCH3),
2.20-1.96 (1 H, m), 1.90 (3 H, s, 4-CH3), 1.60-1.04 (2 H, m), 1.56 (3 H, 
s, 1-CH3) and 1.17 (3 H, s, l ’-CH3); 13C n.m.r. (CDC13) 6C 233.6
(Cr-CO), 141.4 (4-C), 128.4 (7-C), 77.7 and 76.4 (5-, 6- and 8-C), 55.8 
(0CH3), 52.0 ( l ’-C), 32.4 (NCH3), 24.7, 21.2 and 18.9 (3xCH3); MS(m/z) 
395 (M+, 8%), 311 (31, H-3xC0), 259 (7, M-Cr(C0)3), 238 (59), 188 (28)
and 186 (49); Acc. MS(m/z) (Found: 395.1171 (M + , 19%), C2oH25CrN04
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X-RAY CRYSTALLOGRAPHIC DATA
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Table 3
X-Ray Crystallographic Data of (2/?-cis, £ )-(+)-4-(3-Methoxyphenyl)-
2,4-dimethylcyclohexanone oxime (101)
Bond Lengths (Aj
01-N1 - - 1.433 (4) Nl-Cl - - 1.276 (5)
C1-C2 - - 1.504 (6) C1-C6 - - 1.511 (5)
C2-C3 - - 1.526 (6) C3-C4 - - 1.549 (5)
C4-C5 - - 1.534 (6) C4-C8 - - 1.536 (6)
C4-C9 - - 1.528 (6) C5-C6 - - 1.531 (5)
C6-C7 - - 1.527 (6) C9-C10 - - 1.398 (6)
C9-C14 - - 1.392 (6) C10-C11 - - 1.394 (6)
C11-C12 - - 1.366 (6) Cll-02 - - 1.376 (5)
C12-C13 - - 1.378 (6) C13-C14 - - 1.388 (6)
C15-02 - - 1.415 (6)
Intermolecular Distances ( A )
Nl- • • • 0 1 ---------------2.789
Nl- • • • N l --------------- 3.009
01- . . .  0 1 ---------------3.257
Bond Angles (^ _)
01-N1-C1 - - 113.4 (4) C11-02-C15 - - 119.0
N1-C1-C2 - - 126.8 (4) N1-C1-C6 - - 117.3
C1-C2-C3 - - 110.3 (4) C1-C2-C6 - - 115.8
C2-C3-C4 - - 113.9 (3) C3-C4-C5 - - 106.6
C3-C4-C8 - - 108.7 (4) C3-C4-C9 - - 110.3
C5-C4-C8 - - 109.7 (3) C5-C4-C9 - - 108.8
C8-C4-C9 - - 110.8 (3) C4-C5-C6 - - 115.2
C1-C6-C5 - - 109.0 (3) C1-C6-C7 - - 114.4
C5-C6-C7 - - 110.7 (4) C4-C9-C10 - - 121.5
-1 0 9 -
C4-C9-C14 - - 120.9 (4) C9-C10-C11 -  - 120.5 (4)
C9-C10-C14 - - 117.6 (4) 02-C11-C10 - - 123.6 (4)
02-C11-C12 - - 115.2 (4) C10-C11-C12 -  - 121.2 (4)
C11-C12-C13 - - 118.8 (4) C12-C13-C14 -  - 120.9 (5)
C9-C14-C13 - - 120.9 (4)
Fractional Atomic Coordinates ( A )
Atom X y z
01 0.1979(6) 0.1298(3) 0.5146(3)
02 1.2317(6) 0.4339(4) 1.3776(3)
Nl 0.2326(6) 0.0468(3) 0.5833(3)
Cl 0.4284(8) 0.0867(4) 0.6559(4)
C2 0.6129(8) 0.2101(4) 0.6777(4)
C3 0.7069(8) 0.3079(4) 0.8260(4)
04 0.7744(7) 0.2327(4) 0.9102(4)
C5 0.5789(7) 0.1069(4) 0.8793(4)
C6 0.4815(8) 0.0048(4) 0.7317(4)
07 0.2875(8) -0.1151(4) 0.7128(5)
C8 0.9702(8) 0.1806(5) 0.8719(4)
C9 0.8339(7) 0.3330(4) 1.0583(4)
CIO 1.0120(7) 0.3359(4) 1.1484(4)
Cll 1.0599(8) 0.4259(4) 1.2835(4)
C12 0.9369(8) 0.5144(5) 1.3313(5)
C13 0.7601(9) 0.5118(5) 1.2437(5)
C14 0.7077(8) 0.4219(4) 1.1090(4)
C15 1.3404(9) 0.3284(6) 1.4526(5)
-1 1 0 -
T able 4
X-Ray Crystallographic Data of (2^tl ,S^)-(+)-l-(l12-Dihydro-7-methoxy-
l,4-dimethyl-l-naphthyl)-N-methyltrifluoroacetyl-2-propylamine (120)
Bond Lengths ( A )
F1-C16 - - - 1.268(20) F2-C16 - - - 1.331(18)
F3-C16 - - - 1.337(20) N1-C13 - - -  1.498(16)
N1-C14 - - - 1.496(18) N1-C15 - - - 1.340(18)
01-C8 - 1.394(17) 01-C19 - - - 1.415(17)
02-C15 - - - 1.200(17) C1-C2 - 1.566(17)
C1-C10 - - - 1.547(18) C l-C ll - - - 1.572(18)
C1-C12 - - - 1.505(21) C2-C3 - 1.540(20)
C3-C4 - - - 1.335(19) C4-C5 - 1.464(18)
C4-C18 - - - 1.528(18) C5-C6 - 1.363(18)
C5-C10 - - - 1.471(17) C6-C7 - 1.406(19)
C7-C8 - - - 1.394(19) C8-C9 - 1.375(20)
C9-C10 - - - 1.367(18) C12-C13 - - - 1.532(18)
C13-C17 - - - 1.537(21) C15-C16 - - - 1.606(20)
Bond Angles (°)
C14-N1-C13 - 119(1) C15-N1-C13 - 115(1)
C15-N1-C14 - 125(1) C19-01-C8 - 118(1)
C10-C1-C2 - 108(1) C11-C1-C2 - 106(1)
C11-C1-C10 - 109(1) C12-C1-C2 - 109(1)
C12-C1-C10 - 115(1) C12-C1-C11 - 110(1)
C3-C2-C1 - 109(1) C4-C3-C2 - 121(1)
C5-C4-C3 - 121(1) C18-C4-C3 - 122(1)
C18-C4-C5 - 116(1) C6-C5-C4 - 124(1)
C10-C5-C4 - 119(1) C10-C5-C6 - 117(1)
C7-C6-C5 — 123(1) C8-C7-C6 - 118(1)
-1 1 1 -
C7-C8-01 - 123(1) C9-C8-01 - 116(1)
C9-C8-C7 - 121(1) C10-C9-C8 - 121(1)
C5-C10-C1 - 117(1) C9-C10-C1 - 123(1)
C9-C10-C5 - 120(1) C13-C12-C1 - 115(1)
C12-C13-N1 - 112(1) C17-C13-N1 - 107(1)
C17-C13-C12 - 119(1) 02-C15-N1 - 127(1)
C16-C15-N1 - 116(1) C16-C15-02 - 117(1)
F2-C16-F1 - 109(1) F3-C16-F1 - 109(1)
F3-C16-F2 - 106(2) C15-C16-F1 - 112(1)
C15-C16-F2 - 113(1) C15-C16-F3 - 107(1)
Fractional Atomic Coordinates ( A )
Atom X y z
FI 0.36074(13) -0.24521(7) -0.58631(6)
F2 0.18819(15) -0.17923(7) -0.66126(6)
F3 0.13626(16) -0.28228(9) -0.55861(6)
02 0.18229(16) -0.43888(8) -0.65511(6)
Nl 0.3047(14) -0.3490(8) -0.7589(6)
01 -0.2248(14) -0.3831(7) -0.6945(6)
Cl 0.1213(18) -0.4126(10) -0.9378(8)
C2 0.1123(19) -0.3650(10) -1.0304(8)
C3 0.1524(20) -0.2504(12) -1.0256(9)
C4 0.1096(18) -0.1929(10) -0.9589(8)
C5 0.0262(17) -0.2368(10) -0.8867(8)
C6 -0.0501(19) -0.1800(10) -0.8277(8)
C7 -0.1371(19) -0.2244(11) -0.7623(8)
C8 -0.1396(20) -0.3310(10) -0.7555(9)
C9 -0.0620(19) -0.3914(10) -0.8125(8)
CIO 0.0193(16) -0.3490(9) -0.8779(8)
-1 1 2 -
C ll 0.0564(19) -0.5240(9) -0.9462(9)
C12 0.2817(18) -0.4171(10) -0.9103(8)
C13 0.3075(19) -0.4426(10) -0.8150(9)
C14 0.3921(20) -0.2566(11) -0.7854(9)
C15 0.2406(20) -0.3624(11) -0.6818(9)
C16 0.2355(23) -0.2630(13) -0.6207(11)
C17 0.4585(20) -0.4951(11) -0.8004(10)
C18 0.1388(21) -0.0776(10) -0.9545(9)
C19 -0.2753(22) -0.3276(12) -0.6218(10)
Table 5
Least Squares Calculation of the Angle and Distance Between the 
Aromatic Ring the Trifluoroacetamide (120) Carbonyl Group 
Input Data 
a = 8.9918 
b = 13.0422 




Cartesian Coordinates in Angstroms
PlaneAtom X y z
C5 0.248 -3.087 -13.758
C6 -0.439 -2.346 -12.836
C7 -1.248 -2.931 -11.819
C8 -1.243 -4.317 -11.718
C9 -0.582 -5.112 -12.606
-1 1 3 -
CIO 0.181 -4.554 -13.618 1
N1 2.750 -4.553 -11.772 2
02 1.630 -5.725 -10.158 2
C14 3.517 -3.348 -12.183 2
C15 2.169 -4.727 -10.576 2
The Equation of Least Squares (LS) Plane 1 
-0.796601x + -0.017599y + -0.604249z = 8.164528 
The Error is 0.001203
Deviations From Plane 1 for the Points in Plane 1 ( A )
C5 Distance to LS Plane 1 is -0.006
C6 Distance to LS Plane 1 is -0.017
C7 Distance to LS Plane 1 is -0.023
C8 Distance to LS Plane 1 is 0.018
C9 Distance to LS Plane 1 is -0.006
CIO Distance to LS Plane 1 is -0.000
The Equation of Least Squares (LS) Plane 2 
-0.854742x + 0.382833y + -0.350506z = 0.008334 
The Error is 0.003553
Deviations From Plane 2 for the Points in Plane 2 ( A )
N1 Distance to LS Plane 2 is -0.024
02 Distance to LS Plane 2 is 0.032
C14 Distance to LS Plane 2 is 0.026
C15 Distance to LS Plane 2 is -0.035
-1 1 4 -
The Angle Between the Two Least Squares Planes is 27.63°
Distances From Plane 1 ( A )
FI Distance to LS Plane 1 is 5.192
F2 Distance to LS Plane 1 is 3.285
F3 Distance to LS Plane 1 is 3.830
N1 Distance to LS Plane 1 is 3.167
02 Distance to LS Plane 1 is 3.222
C13 Distance to LS Plane 1 is 2.645
C14 Distance to LS Plane 1 is 3.553
C15 Distance to LS Plane 1 is 3.418
C16 Distance to LS Plane 1 is 3.982





















































































2D COSY of ( ) (l/?,2S,4/?,6/?)-l,2,3,4,5,6-Hexahydro-8-methoxy-l,3,4,6- 
tetramethyl-2,6-methano-3-benzazocine
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1 3 C n.m.r. of (-)-(Iff ,2S ,4ff ,6R )-l,2,3,4,5,6-Hexahydro-8-methoxy-
-l,3,4,6-tetramethyl-2,6-methano-3-benzazocine
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